
<html lang="en"     class="pb-page"  data-request-id="6b573a9a-7858-4f67-be1c-9452f467b06a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2009.52.issue-12;website:website:acspubs;article:article:10.1021/jm801632a;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles" /></meta><meta name="dc.Creator" content="Stéphane L.  Bogen" /></meta><meta name="dc.Creator" content="Weidong  Pan" /></meta><meta name="dc.Creator" content="Sumei  Ruan" /></meta><meta name="dc.Creator" content="Latha G.  Nair" /></meta><meta name="dc.Creator" content="Ashok  Arasappan" /></meta><meta name="dc.Creator" content="Frank  Bennett" /></meta><meta name="dc.Creator" content="Kevin X.  Chen" /></meta><meta name="dc.Creator" content="Edwin  Jao" /></meta><meta name="dc.Creator" content="Srikanth  Venkatraman" /></meta><meta name="dc.Creator" content="Bancha  Vibulbhan" /></meta><meta name="dc.Creator" content="Rong  Liu" /></meta><meta name="dc.Creator" content="Kuo-Chi  Cheng" /></meta><meta name="dc.Creator" content="Zhuyan  Guo" /></meta><meta name="dc.Creator" content="Xiao  Tong" /></meta><meta name="dc.Creator" content="Anil K.  Saksena" /></meta><meta name="dc.Creator" content="Viyyoor  Girijavallabhan" /></meta><meta name="dc.Creator" content="F. George  Njoroge" /></meta><meta name="dc.Description" content="Hepatitis C is the most prevalent liver disease. Viral hepatitis C (HCV), a small (+)-RNA virus, infects chronically an estimated 300 million people worldwide. Results of Phase I clinical studies w..." /></meta><meta name="Description" content="Hepatitis C is the most prevalent liver disease. Viral hepatitis C (HCV), a small (+)-RNA virus, infects chronically an estimated 300 million people worldwide. Results of Phase I clinical studies w..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 20, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm801632a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm801632a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm801632a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm801632a" /></link>
        
    
    

<title>Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm801632a" /></meta><meta property="og:title" content="Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0015.jpeg" /></meta><meta property="og:description" content=" Hepatitis C is the most prevalent liver disease. Viral hepatitis C (HCV), a small (+)-RNA virus, infects chronically an estimated 300 million people worldwide. Results of Phase I clinical studies with our first generation HCV inhibitor Boceprevir, SCH 503034 (1), presented at the 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) were encouraging, and thus, additional human clinical studies are underway. In view of the positive data from our first generation compound, further work aimed at optimizing its overall profile was undertaken. Herein, we report that extension of our earlier inhibitor to the P4 pocket and optimization of the P1′ capping led to the discovery of new ketoamide inhibitors of the HCV NS3 serine protease with improved in vitro potency. In addition to being potent inhibitors of HCV subgenomic RNA replication, some of the new P4-capped inhibitors were also found to have improved PK profile." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm801632a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm801632a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm801632a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm801632a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm801632a&amp;href=/doi/10.1021/jm801632a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 3679-3688</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm801609s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900022f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P<sub>4</sub>-Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=St%C3%A9phane+L.++Bogen">Stéphane L. Bogen</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weidong++Pan">Weidong Pan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sumei++Ruan">Sumei Ruan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Latha+G.++Nair">Latha G. Nair</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashok++Arasappan">Ashok Arasappan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Bennett">Frank Bennett</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+X.++Chen">Kevin X. Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edwin++Jao">Edwin Jao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srikanth++Venkatraman">Srikanth Venkatraman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bancha++Vibulbhan">Bancha Vibulbhan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rong++Liu">Rong Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kuo-Chi++Cheng">Kuo-Chi Cheng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhuyan++Guo">Zhuyan Guo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao++Tong">Xiao Tong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anil+K.++Saksena">Anil K. Saksena</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Viyyoor++Girijavallabhan">Viyyoor Girijavallabhan</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+George++Njoroge">F. George Njoroge</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 908-740-4642. Fax: 908-740-7152. E-mail: <a href="/cdn-cgi/l/email-protection#07747362776f666962296568606269477477646875772964686a"><span class="__cf_email__" data-cfemail="c5b6b1a0b5ada4aba0eba7aaa2a0ab85b6b5a6aab7b5eba6aaa8">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm801632a&amp;href=/doi/10.1021%2Fjm801632a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 3679–3688</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 20, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 December 2008</li><li><span class="item_label"><b>Published</b> online</span>20 May 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 June 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm801632a" title="DOI URL">https://doi.org/10.1021/jm801632a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3679%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSt%25C3%25A9phane%2BL.%2BBogen%252C%2BWeidong%2BPan%252C%2BSumei%2BRuan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D12%26contentID%3Djm801632a%26title%3DToward%2Bthe%2BBack-Up%2Bof%2BBoceprevir%2B%2528SCH%2B503034%2529%253A%2BDiscovery%2Bof%2BNew%2BExtended%2BP4-Capped%2BKetoamide%2BInhibitors%2Bof%2BHepatitis%2BC%2BVirus%2BNS3%2BSerine%2BProtease%2Bwith%2BImproved%2BPotency%2Band%2BPharmacokinetic%2BProfiles%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3688%26publicationDate%3DJune%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm801632a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2594</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm801632a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Stéphane&quot;,&quot;last_name&quot;:&quot;L. Bogen&quot;},{&quot;first_name&quot;:&quot;Weidong&quot;,&quot;last_name&quot;:&quot;Pan&quot;},{&quot;first_name&quot;:&quot;Sumei&quot;,&quot;last_name&quot;:&quot;Ruan&quot;},{&quot;first_name&quot;:&quot;Latha&quot;,&quot;last_name&quot;:&quot;G. Nair&quot;},{&quot;first_name&quot;:&quot;Ashok&quot;,&quot;last_name&quot;:&quot;Arasappan&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Bennett&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;X. Chen&quot;},{&quot;first_name&quot;:&quot;Edwin&quot;,&quot;last_name&quot;:&quot;Jao&quot;},{&quot;first_name&quot;:&quot;Srikanth&quot;,&quot;last_name&quot;:&quot;Venkatraman&quot;},{&quot;first_name&quot;:&quot;Bancha&quot;,&quot;last_name&quot;:&quot;Vibulbhan&quot;},{&quot;first_name&quot;:&quot;Rong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Kuo-Chi&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Zhuyan&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Xiao&quot;,&quot;last_name&quot;:&quot;Tong&quot;},{&quot;first_name&quot;:&quot;Anil&quot;,&quot;last_name&quot;:&quot;K. Saksena&quot;},{&quot;first_name&quot;:&quot;Viyyoor&quot;,&quot;last_name&quot;:&quot;Girijavallabhan&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;George Njoroge&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;3679-3688&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm801632a&quot;},&quot;abstract&quot;:&quot;Hepatitis C is the most prevalent liver disease. Viral hepatitis C (HCV), a small (+)-RNA virus, infects chronically an estimated 300 million people worldwide. Results of Phase I clinical studies with our first generation HCV inhibitor Boceprevir, SCH 503034 (1), presented at the 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) were encouraging, and thus, additional human clinical studies are underway. In view of the positive data from our first generation compound, further work aimed at optimizing its overall profile was undertaken. Herein, we report that extension of our earlier inhibitor to the P4 pocket and optimization of the P1′ capping led to the discovery of new ketoamide inhibitors of the HCV NS3 serine protease with improved in vitro potency. In addition to being potent inhibitors of HCV subgenomic RNA replication, some of the new P4-capped inhibitors were also found to have improved PK profile.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801632a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801632a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801632a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801632a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801632a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801632a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm801632a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801632a&amp;href=/doi/10.1021/jm801632a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm801632a" /></input><a href="/doi/pdf/10.1021/jm801632a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (336 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm801632a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm801632a%26sid%3Dliteratum%253Aachs%26pmid%3D19456105%26genre%3Darticle%26aulast%3DBogen%26date%3D2009%26atitle%3DToward%2Bthe%2BBack-Up%2Bof%2BBoceprevir%2B%2528SCH%2B503034%2529%253A%2BDiscovery%2Bof%2BNew%2BExtended%2BP4-Capped%2BKetoamide%2BInhibitors%2Bof%2BHepatitis%2BC%2BVirus%2BNS3%2BSerine%2BProtease%2Bwith%2BImproved%2BPotency%2Band%2BPharmacokinetic%2BProfiles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D12%26spage%3D3679%26epage%3D3688%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291945" title="Ketones">Ketones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Hepatitis C is the most prevalent liver disease. Viral hepatitis C (HCV), a small (+)-RNA virus, infects chronically an estimated 300 million people worldwide. Results of Phase I clinical studies with our first generation HCV inhibitor Boceprevir, SCH 503034 (<b>1</b>), presented at the 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) were encouraging, and thus, additional human clinical studies are underway. In view of the positive data from our first generation compound, further work aimed at optimizing its overall profile was undertaken. Herein, we report that extension of our earlier inhibitor to the P<sub>4</sub> pocket and optimization of the P<sub>1</sub>′ capping led to the discovery of new ketoamide inhibitors of the HCV NS3 serine protease with improved in vitro potency. In addition to being potent inhibitors of HCV subgenomic RNA replication, some of the new P<sub>4</sub>-capped inhibitors were also found to have improved PK profile.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50734" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50734" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis C is the most prevalent liver disease. Viral hepatitis C (HCV<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: HCV, hepatitis C virus; DM periodinane, Dess−Martin’s periodinane; Cys159, cysteine159; C<sub>6h</sub>, liver concentration at 6 h.</p></div> ), a small (+)-RNA virus, infects chronically an estimated 300 million people worldwide. HCV displays genetic heterogeneity with the genotype 1 being most common in the U.S., Europe, and Japan, and the most challenging to eradicate. Untreated HCV infections can progress to cirrhosis, hepatocellular carcinoma, and liver failure, a primary cause for liver transplantation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Subcutaneous and intramuscular injections of α interferons (immune system booster) have been used since the late 1980s in the treatment of chronic hepatitis C. Currently, PEGylated-interferon in combination with antiviral drug ribavirin has brought the rate of sustained virological response to approximately 50% in patients infected with the genotype 1.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although the use of α interferons is an integral component in the management of chronic hepatitis C infection, major adverse events can occur and subsequently result in dose reduction or discontinuation of treatment. Thus, several research groups have been working toward development of a more effective, convenient, and tolerable treatment.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Upon entering a liver cell, the hepatitis C virus dissociates, liberating the viral RNA genome. The HCV genome serves as a template for cap-independent translation through an internal ribosome entry (IRES) located in the 5′ untranslated region. The resulting polyprotein undergoes both co- and post-translational proteolytic maturation by host and virally encoded proteases. The NS3 serine protease, a pivotal enzyme required for maturation of hepatitis C virons, assists in processing of the HCV polyprotein by cleaving four downstream sites. Because of its central role in viral replication,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> inhibition of HCV NS3 serine protease has been actively pursued as target for antiviral therapy.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">The Boehringer Ingelheim group was the first one to report phase Ib clinical antiviral efficacy with BILN 2061, a competitive inhibitor of the HCV NS3 serine protease.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Derivatives containing an α-ketoamide electrophilic trap have been reported by our group<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and others<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> to be potent inhibitors of HCV NS3 serine protease. Recently, we published our work that led to the identification of our first generation clinical candidate Boceprevir, (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-amino-1-(cyclobutylmethyl)-2−3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)-amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2(<i>S</i>)-carboxamide (SCH 503034), <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Clinical candidates (1<i>S</i>,3a<i>R</i>,6a<i>S</i>)-2-((<i>S</i>)-2-((<i>S</i>)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-<i>N</i>-((<i>S</i>)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[<i>c</i>]pyrrole-1-carboxamide (VX950) and <b>1</b> belonging to the α-ketoamide series established proof-of-concept in the aforementioned studies.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Recently, several other NS3 protease inhibitors have been advanced to clinical trial.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Results of phase I clinical studies with <b>1</b>, presented at the 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in November 2005, were encouraging.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The drug was rapidly absorbed, well tolerated, and demonstrated potent antiviral activity, both as monotherapy and in combination with peginterferon α-2b. Phase II clinical studies of <b>1</b> are still underway, and phase III trials have been initiated. Consequently, further work aimed at optimizing the overall profile of our first generation inhibitor was undertaken.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Profile of <b>1</b> (SCH 503034).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While investigating the P<sub>3</sub> capping SAR that led to the discovery of <b>1</b>, we noticed that incorporation of the larger hydrophobic moiety in <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) achieved improvement both in enzyme and in cellular activity compared to <b>1</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Profile of <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Exploring the scope of the 1-substituted-cyclohexyl ureas series, we discovered that incorporation of a benzyl ester moiety provided a dramatic improvement of the cell potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compound <b>20</b>, EC<sub>90</sub> = 20 nM) compared to <b>1</b>. Herein, we report our finding that led to the discovery of new P<sub>4</sub> extended ketoamide inhibitors of the HCV NS3 serine protease with improved potency and DMPK properties.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 1. <a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0002.gif" alt="" id="gr4" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0003.gif" alt="" id="gr5" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub>* value represents binding for a mixture of diastereomers at P<sub>1</sub> and within 2-fold for 95% confidence limit; Replicon (genotype 1) EC<sub>90</sub> value is within 3-fold for 95% confidence (single assay) and within 2-fold for 95% confidence (multiple assays).</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">P<sub>1</sub> cyclobutylalanine.</p></div></div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Chemistry</h3><div class="NLM_p">Synthesis of the inhibitors was generally carried out as depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The <i>gem</i>-dimethylcyclopropylproline P<sub>2</sub> core <b>3</b> was known to be essential for potency and was used to prepare the Boc-protected P<sub>3</sub> amino acid, dipeptide <b>4</b> according previously described protocols.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a> With the goal of exploring the P<sub>4</sub> area, we identified <b>6</b> as a key intermediate. Thus, acid <b>4</b> was coupled with the appropriate P<sub>1</sub> hydroxyamides <b>5</b> following standard HATU coupling methodology. Oxidation of primary hydroxyamide and secondary hydroxyamide moieties was accomplished using Moffatt and Dess−Martin conditions, respectively.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> After Boc removal, intermediate <b>6</b> was reacted with isocyanates of type <b>7</b> to efficiently deliver targets of type <b>8</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0013.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) (i) Boc-<i>t</i>-leucine, EDC, HOOBt; DMF/CH<sub>2</sub>Cl<sub>2</sub>, iPr<sub>2</sub>NEt, 0 °C; (ii) LiOH, THF·MeOH/H<sub>2</sub>O, 0 °C; (b) (i) HATU, DMF, DIPEA, −20 °C; (ii) Cl<sub>2</sub>CO<sub>2</sub>H, EDCI·HCl, DMSO, 0 °C (R′ = H); Dess−Martin periodinane, RT (R′ = alkyls); (iii) 4 M HCl; <i>p</i>-dioxane, RT; (c) CH<sub>2</sub>Cl<sub>2</sub>, iPr<sub>2</sub>NEt, 0 °C.</p></p></figure><div class="NLM_p">The various capping moieties were prepared according to the general procedures outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Esterification of protected amino acid <b>9</b> bearing the desired functionality R<sup>4</sup> proceeded smoothly using EDCI and 4-DMAP to yield structures of type <b>10</b>. Standard HATU coupling delivered corresponding amides of type <b>11</b>. Ketones of type <b>12</b> were prepared by reacting various Grignard or organolithium reagents with the appropriate Weinreb amide. Finally, Boc removal from intermediates <b>10</b>−<b>12</b> and subsequent treatment of the amine salts with phosgene in aqueous sodium bicarbonate led to the corresponding isocyanates of type <b>7</b> that were needed for P<sub>4</sub> capping exploration.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0014.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) EDCI, 4-DMAP, ROH, 0 °C; (b) HATU, DMF, DIPEA, R’NH<sub>2</sub>, −20 °C. (c) (i) EDCI, NMM, HCl·HN(OMe)Me, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (ii) R′′MgBr or R′′MgCl or R′′Li, Et<sub>2</sub>O or THF, −78 °C. (d) (i) 4 M HCl <i>p</i>-dioxane, RT; (ii) phosgene, NaHCO<sub>3</sub>, H<sub>2</sub>O /CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><div class="NLM_p">Derivatization of ketone <b>13</b> was accomplished according to Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The alkene analogue <b>14</b> was prepared from <b>13</b> using a Peterson olefination.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Sodium borohydride reduction in MeOH generated the benzylic alcohol <b>15</b> that was further hydrogenated to <b>16</b> using Pd/C. Phenyl ketone <b>13</b> was reacted with <i>O</i>-methylhydroxylamine in pyridine to provide oximes <b>17</b> as a mixture of isomers. Isocyanates <b>18</b> were prepared from their corresponding HCl or TFA salt following the aforementioned conditions.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0001.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) (i) TMSCH<sub>2</sub>MgCl, THF, 0 °C; (ii) KHMDS, THF, 0 °C; (iii) 4 M HCl <i>p</i>-dioxane, RT. (b) (i) NaBH<sub>4</sub>, MeOH, 0 °C (R = OH); (ii) H<sub>2</sub>, MeOH, 10%Pd/C, RT (R = H); (iii) 4 M HCl <i>p</i>-dioxane, RT. (c) (i) MeONH<sub>2</sub>.HCl, pyridine, 50 °C; (ii) 50% TFA in CH<sub>2</sub>Cl<sub>2</sub>, RT. (d) Phosgene, NaHCO<sub>3</sub>, H<sub>2</sub>O /CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inhibitors listed in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>,<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>−<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were tested in continuous assay using the NS4A-tethered single chain NS3 serine protease.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> HCV replicon inhibitory activity for the targets synthesized was obtained using previously reported assay.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As a general trend, compounds listed in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>,<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>−<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> had GAPDH CC<sub>50</sub> > 5 μM when tested in counter screen measuring cellular toxicity and maintained good selectivity vs HNE similar to previously reported inhibitors.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a> We evaluated our initial set of P<sub>4</sub> extended inhibitors <b>19</b>−<b>32</b> listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> by varying the R<sup>1</sup> moieties. The P<sub>1</sub> was kept constant as a cyclopropyl or cyclobutyl alanine residue. as these two motifs previously provided similar binding potencies. The <i>tert</i>-Leucine moiety, which was previously optimized as a P<sub>3</sub> surrogates, was used during that entire study.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a> As reported earlier, the nature of P<sub>3</sub> capping could greatly influence the enzyme activity. While investigating newer substitutions, we observed that the use of 1-methyl-cyclohexyl urea as a P<sub>3</sub> capping group in inhibitor <b>19</b> boosted further the enzyme and replicon activity by 2-fold compared to <b>1</b>. While exploring the scope of the 1-substituted-cyclohexyl ureas, we discovered that the incorporation of a benzyl ester moiety provided inhibitor <b>20</b> with a dramatic 10-fold improvement in cell potency (EC<sub>90</sub> = 20 nM) compared to <b>19</b>. Inhibitor <b>20</b> was the first of its class to show such enhanced activity in the replicon assay. PAMPA permeability of similar analogues was recently disclosed in a communication and seemed to correlate well with cellular activity.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Because of the improved cell potency, we quickly explored the SAR of this new series and we identified additional esters that showed low EC<sub>90</sub> in the replicon assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compound <b>21</b>−<b>23</b>). Aromatic moieties seemed essential for improvement in potency, whereas alkyl esters were less potent (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compound <b>24</b>, <b>25</b>). Modification of the benzyl ester moiety to a benzyl ether <b>26</b> and benzoyl ester <b>27</b> resulted in a significant loss in cellular activity. Although the carbonyl group seemed to be required for potency, phenyl ketone <b>28</b> (<i>K</i><sub>i</sub>* = 100 nM) showed weak enzyme activity and cell potency. Benzyl amide <b>29</b> was also found to be less active. The rat and monkey pharmacokinetic properties of inhibitor <b>20</b> were investigated, and the data is summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Clearance values reported for compound <b>20</b> indicated moderate metabolic stability in rat but low in monkey (rat Cl = 28 mL/min/kg, monkey Cl = 43 mL/min/kg). Cynomolgus monkeys (<i>n</i> = 2) were dosed at 2 mg/kg PO with the <sup>14</sup>C ketoamide of <b>20</b>. There was no observed radioactivity for the plasma sample. The (0−24 h) recovery of radioactivity (% of oral dose) was 4.3% in bile and 0.8% in urine. Furthermore, the major response in bile was generated by the ester hydrolysis metabolite <b>30</b>. Unfortunately, while retaining good enzyme potency (<i>K</i><sub>i</sub>* = 9 nM), the carboxylic acid <b>30</b> completely lacked activity in cell assay (EC<sub>90</sub> = 5 μM), conceivably due to poor cell penetration. Carboxylic acid isostere <b>31</b> was prepared, but the acid sulfonamide showed weak enzyme potency and poor activity in cell (<i>K</i><sub>i</sub>* = 110 nM, EC<sub>90</sub> = 5 μM). Hindered ester <b>32</b> (<i>K</i><sub>i</sub>* = 80 nM, EC<sub>90</sub> = 600 nM) was synthesized in an attempt to improve pharmacokinetics properties. Unfortunately, introduction of steric bulk at the benzylic position, primarily architectured to prevent hydrolysis, led to a decrease in both enzyme and cell potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Full Rat and Monkey Pharmacokinetic Properties of Inhibitor <b>20</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle">rat</th><th align="center" valign="middle">monkey</th></tr></thead><tbody><tr valign="top"><td align="left">AUC (PO)</td><td align="left">0</td><td align="left">0.05</td></tr><tr valign="top"><td align="left">AUC (IV)</td><td align="left">9.3</td><td align="left">3.4</td></tr><tr valign="top"><td align="left"><i>t</i><sub>1/2</sub> (IV)</td><td align="left">2.9</td><td align="left">3.1</td></tr><tr valign="top"><td align="left">Cl</td><td align="left">28</td><td align="left">43</td></tr><tr valign="top"><td align="left"><i>V</i><sub>d(ss)</sub></td><td align="left">3.5</td><td align="left">1.7</td></tr><tr valign="top"><td align="left"><i>F</i> (PO)</td><td align="left">0</td><td align="left">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">AUC(μM·h); <i>t</i><sub>1/2</sub> (h); Cl(mL/min/kg); <i>V</i><sub>d(ss)</sub> (L/kg); <i>F</i> (%); rat PO and IV were dosed at 10 mpk, 3 animals; monkey PO and IV were dosed at 3 mpk, 3 animals; vehicle: rat IV (40%HPBCD); monkey IV (20%HPBCD); rat and monkey PO (0.4%MC).</p></div></div></div><div class="NLM_p">The improved cellular activity demonstrated by compound <b>20</b> in comparison to <b>1</b> prompted us to further investigate the SAR of various P<sub>4</sub> residues. Compounds prepared to evaluate this effect are outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Regarding spirocycloalkyl series, compounds with the larger ring sizes such as compounds <b>20</b> and <b>33</b> had optimal potency, whereas those with smaller ring sizes such as spirocyclopropyl analogue <b>34</b> (<i>K</i><sub>i</sub>* = 170 nM and EC<sub>90</sub> = 1000 nM) lost potency. Incorporation of 2-aminoisobutyric acid as the P<sub>4</sub> residue resulted in compound <b>35</b> with <i>K</i><sub>i</sub>* = 210 nM, a similar activity to derivative <b>34</b>. Inhibitors <b>36</b> (<i>K</i><sub>i</sub>* = 290 nM) and <b>37</b> (<i>K</i><sub>i</sub>* = 44 nM) having <span class="smallcaps smallerCapital">d</span> and <span class="smallcaps smallerCapital">l</span> α methyl valine were used to establish which stereochemistry at P<sub>4</sub> was required for activity. Further evaluation of the P<sub>4</sub> residues was done by using various <span class="smallcaps smallerCapital">l</span> amino acids; incorporation of <span class="smallcaps smallerCapital">l</span>-valine provided <b>38</b> (<i>K</i><sub>i</sub>* = 13 nM and EC<sub>90</sub> = 35 nM), a potent inhibitor in both enzyme and replicon assay. The bulkier <i>tert</i>-butyl group in inhibitor <b>39</b> (<i>K</i><sub>i</sub>* = 67 nM) was detrimental to the enzyme activity. We further probed the P<sub>4</sub> region, and we discovered that small <span class="smallcaps smallerCapital">l</span>-cycloakyls amino acids were well tolerated. Thus, incorporation of cyclopropyl, cyclopentyl, and cyclohexyl glycine resulted in inhibitors <b>40</b>, <b>41</b>, and <b>42</b>, respectively, with improved enzyme and cell potency. In summary, SAR studies of P<sub>4</sub> groups identified <span class="smallcaps smallerCapital">l</span>-valine and <span class="smallcaps smallerCapital">l</span>-cycloakyls amino acids as optimal substituent that provided improved enzyme binding as well as cellular activity. Commercially available <span class="smallcaps smallerCapital">l</span>-valine and <span class="smallcaps smallerCapital">l</span>-cyclohexyl glycine were used to further investigate SAR, and the results are outlined in Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 3. <a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0004.gif" alt="" id="gr9" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0005.gif" alt="" id="gr10" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub>* value represents binding for a mixture of diastereomers at P<sub>1</sub> and within 2-fold for 95% confidence limit; Replicon (genotype 1) EC<sub>90</sub> value is within 3-fold for 95% confidence (single assay) and within 2-fold for 95% confidence (multiple assays).</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">Not tested (nt).</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 4. <a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0006.gif" alt="" id="gr11" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0007.gif" alt="" id="gr12" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub>* value represents binding for a mixture of diastereomers at P<sub>1</sub> and within 2-fold for 95% confidence limit; replicon (genotype 1) EC<sub>90</sub> value is within 3-fold for 95% confidence (single assay) and within 2-fold for 95% confidence (multiple assays).</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Not tested (nt).</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 5. <a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0008.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0009.gif" alt="" id="gr14" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub>* value represents binding for a mixture of diastereomers at P<sub>1</sub> and within 2-fold for 95% confidence limit; replicon (genotype 1) EC<sub>90</sub> value is within 3-fold for 95% confidence (single assay) and within 2-fold for 95% confidence (multiple assays).</p></div></div></div><div class="NLM_p">As observed in the spirocyclohexyl P<sub>4</sub> series, introduction of steric bulk at the benzylic position in compound <b>43</b> led to a 17-fold decrease in cell potency compare with <b>38</b>. The acid sulfonamide <b>44</b> (<i>K</i><sub>i</sub>* = 6 nM) was also prepared with <span class="smallcaps smallerCapital">l</span>-valine at P<sub>4</sub> and provided 18-fold improvement in enzyme potency compared to <b>31</b> (<i>K</i><sub>i</sub>* = 110 nM), but cell potency remained poor (EC<sub>90</sub> = 5 μM). Tetrazole analogue <b>45</b> was made but like the other carboxylic acid isostere previously evaluated, it exhibited excellent enzyme potency but weak replicon activity (<i>K</i><sub>i</sub>* = 10 nM, EC<sub>90</sub> = 1 μM). In contrast with the spirocyclohexyl P<sub>4</sub> series, incorporation of a phenyl ketone in the <span class="smallcaps smallerCapital">l</span>-valine series yielded inhibitor <b>46</b> with more than 20-fold improvement in both enzyme and replicon activity when compared to compound <b>28</b>. In addition to good potency, inhibitor <b>46</b> also showed some exposure after oral administration in rats (AUC = 0.26 μM.hr). Simple modifications of the ketone moiety demonstrated that this functional group was essential for activity with compounds <b>47</b>−<b>51</b> exhibiting more than 10-fold loss in enzyme potency. With this information in hand, we further explored the ketone series by introducing various aromatic and alkyl modifications. Incorporation of a pyridine group improved the PK profile of analogue <b>52</b> but resulted in some decrease in cell potency (EC<sub>90</sub> = 200 nM) as compared to <b>46</b> (EC<sub>90</sub> = 80 nM). The thiophene and thiazole analogues <b>53</b> and <b>54</b> were almost equipotent to the phenyl ketone <b>46</b> but did not show better oral PK in rat. We then looked at small cycloakyl and alkyl substituents. Thus, cyclopropyl ketone <b>55</b>, cyclobutyl ketone <b>56</b>, and cyclohexyl ketones <b>57</b> were prepared. The smaller cyclopropyl group seemed optimal for both enzyme and replicon potency with similar overall profile compared to the original ketone <b>46</b>. Small alkyls groups were also probed (compounds <b>58</b>−<b>60</b>) but did not provide any improvements over previous compounds. As established earlier in the ester series, incorporation of cyclohexyl glycine at P<sub>4</sub> provided inhibitor <b>42</b> with better overall potency profile. With that information in hand, we prepared the 2-pirydine ketone analogue <b>61</b> with the aim of enhancing the replicon potency of this series. Interestingly, through this manipulation, we were able to improve the cell potency of <b>61</b> to EC<sub>90</sub> = 90 nM and also obtain an inhibitor with good oral exposure and liver concentration in rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Similar improvement of pharmacokinetics profile for the cyclopropyl ketone <b>62</b> was observed when combined with the cyclohexylglycine at P<sub>4</sub>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rapid Rat PK Data for Selected Compounds<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">AUC (μM·h)<sub>0−6 h</sub></th><th align="center" valign="middle">liver conc (μM)<sub>6h</sub></th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left">0.14</td><td align="left">0.3<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></td></tr><tr valign="top"><td align="left"><b>45</b></td><td align="left">0.26</td><td align="left">nd<a class="ref internalNav" href="#tbl6-fn3" aria-label="c">c</a></td></tr><tr valign="top"><td align="left"><b>52</b></td><td align="left">0.42</td><td align="left">nd</td></tr><tr valign="top"><td align="left"><b>53</b></td><td align="left">0.08</td><td align="left">nd</td></tr><tr valign="top"><td align="left"><b>54</b></td><td align="left">0.15</td><td align="left">nd</td></tr><tr valign="top"><td align="left"><b>55</b></td><td align="left">0.12</td><td align="left">nd</td></tr><tr valign="top"><td align="left"><b>61</b></td><td align="left">1.4</td><td align="left">0.8</td></tr><tr valign="top"><td align="left"><b>62</b></td><td align="left">1.4</td><td align="left">2.7</td></tr><tr valign="top"><td align="left"><b>63</b></td><td align="left">26</td><td align="left">nd</td></tr><tr valign="top"><td align="left"><b>64</b></td><td align="left">55</td><td align="left">5.8</td></tr><tr valign="top"><td align="left"><b>67</b></td><td align="left">24</td><td align="left">8.5</td></tr><tr valign="top"><td align="left"><b>68</b></td><td align="left">11</td><td align="left">2.9</td></tr><tr valign="top"><td align="left"><b>69</b></td><td align="left">4.8</td><td align="left">0.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Rat PO were dosed at 10 mpk (no IV arm). Number of animals used: 2. Vehicle: PO (40%HPBCD).</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">Rat liver concentration at 8 h.</p></div><div class="footnote" id="tbl6-fn3"><sup>c</sup><p class="last">Rat liver concentration in was not determined (nd).</p></div></div></div><div class="NLM_p">During our earlier exploratory studies that led to the discovery of <b>1</b>, we observed that P<sub>1</sub>′ secondary amides, especially allyl amides, when used in combination with norvaline at P<sub>1</sub> provided inhibitors with very good rat PK profile but weak enzyme and replicon potency.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a> With the improved potency of our P<sub>4</sub>-capped inhibitors, we decided to introduce the allyl residue at the P<sub>1</sub>′ position with the goal of further improving the PK profile. Thus, the nor-valine P<sub>1</sub> and allyl amide P<sub>1</sub>′ combinations were used to generate inhibitors <b>63</b> and <b>64</b> bearing the cyclopropyl ketone moiety. Introduction of the allyl moiety at P<sub>1</sub>′ resulted in compounds with poorer cellular activity compared to primary amide derivatives <b>55</b> and <b>61</b>, however, they exhibited excellent rat PK with oral exposure improved by 40- to 200-fold, respectively. In addition, concentration in the liver for inhibitor <b>64</b> was also very high (5.8 μM at 6 h). To further improve the cellular activity of these inhibitors, we decided to explore the effect of variation of P<sub>1</sub> residue. From our previous experience with the discovery of <b>1</b>, we were aware of the fact that the P<sub>1</sub> norvaline was not the optimal substitution.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a> Cyclopropyl alanine analogue <b>65</b> and norleucine analogues <b>66</b> were prepared but provided similar weak replicon potency. However, from Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, it was clear that introduction of butynylglycine at P<sub>1</sub> had a profound effect on the cellular potency of compound <b>67</b> (<i>K</i><sub>i</sub>* = 9 nM, EC<sub>90</sub> = 250 nM) compared to earlier inhibitors. Furthermore, <b>67</b> exhibited very good rat oral exposure (AUC(μM·h)<sub>0−6 h</sub> = 24) and high concentration in the liver (8.5 μM at 6 h) (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Because of the potential in vivo liability of the allyl moiety, we turned our effort toward the identification of a more desirable surrogates at P<sub>1</sub>′. Replacement of the allyl group with cyclopropyl resulted in compound <b>68.</b> The cyclopropyl at P<sub>1</sub>′ was well tolerated and resulted in 5-fold improvement in cell potency (EC<sub>90</sub> = 55 nM) compared to the allyl amide analogue <b>67</b> (EC<sub>90</sub> = 250 nM). Similar potency profile was achieved when the P<sub>1</sub> butynylglycine and P<sub>1</sub>′ cyclopropyl amide combinations were used with <span class="smallcaps smallerCapital">l</span>-valine at P<sub>4</sub> to generate inhibitor <b>69</b> (EC<sub>90</sub> = 70 nM). However, as observed earlier with <b>59</b> and <b>62</b>, the cyclohexylglycine at P<sub>4</sub> in inibitor <b>68</b> (AUC(μM·h)<sub>0−6 h</sub> = 11) provided better oral exposure compared to the <span class="smallcaps smallerCapital">l</span>-valine residue as in inibitor <b>69</b> (AUC(μM·h)<sub>0−6 h</sub> = 4.8).</div><div class="NLM_p">To understand the interactions, especially the P<sub>4</sub> and P<sub>4</sub> cap, with the protein, compound <b>68</b> was modeled in the active site of the NS3/NS4A protease domain (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Similar to the <i>t</i>-butyl glycine P<sub>3</sub> cap of compound <b>1</b>, the P<sub>4</sub> cyclohexyl glycine binds to the S<sub>4</sub> subsite, which is a shallow hydrophobic pocket consisting of residues Arg 123, Asp 168, Arg 155, Ala 156, and Val 158. The cyclopropyl P<sub>4</sub> cap sits on top of Val 158 side chain. The ketone oxygen points toward the solvent. The favorable hydrophobic contacts of the P<sub>4</sub> cyclopropyl cap with the side chain of Val 158 may attribute to the enhancement in enzyme potency of compound <b>68</b> compared with <b>1</b>.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0010.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of compound <b>68</b> bound to the active site of HCV NS3/NS4A protease domain. The inhibitor is shown as stick and the protein as surface. The S1−S4 subsites and the residues that occupy the S4 pocket are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">As we moved toward the back-up for <b>1</b>, we discovered that P<sub>4</sub>-capped inhibitors could provide enhanced enzyme and cellular potency. Initially, we identified novel series of P<sub>4</sub> ester derived inhibitors that showed 18-fold improvements in cellular potency (EC<sub>90</sub>) but lacked oral exposure in rat. Derivatization of the ester and optimization of the P<sub>4</sub> residue led to the identification of the ketone series that provided compounds with excellent enzyme potency, improved replicon activity, and modest oral exposure in rat. Modification of the primary amide P<sub>1</sub>′ capping group to a secondary allyl amide drastically improved rat oral exposure but resulted in weak cell potency. By systematic optimization of the P<sub>1</sub> and the P<sub>1</sub>′ residues, P<sub>1</sub> butynylglycine and P<sub>1</sub>′ cyclopropyl amide were identified as moieties that, when used in combination, provided compounds with excellent binding and much improved cellular potencies over <b>1</b>. Evaluation of these potent compounds in rapid rats allowed us to identify inhibitor <b>68</b> with excellent enzyme and replicon potency (<i>K</i><sub>i</sub>* = 4 nM and EC<sub>90</sub> = 55 nM) and with an improved oral exposure in rats (AUC = 11 μM·h) compared to <b>1</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NMR spectra were recorded at 300, 400, or 500 MHz for <sup>1</sup>H and at 75, 100, or 125 MHz for <sup>13</sup>C on a Bruker or Varian spectrometer with CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvent, respectively. The chemical shifts are given in ppm, referenced to the internal TMS or deuterated solvent signal.</div><div class="NLM_p">General experimental procedures were described in earlier publications<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> for the synthesis of P2 core, peptide coupling, Boc group deprotection, hydrolysis of ester to carboxylic acid, and Dess−Martin periodinane oxidation. The syntheses of ketones and analogues were performed from various starting material according to literature procedures with some minor modifications.</div><div class="NLM_p">Purity of target compounds were determined using LC-MS analysis. LC-MS analyses were performed using an Applied Biosystems API-150 mass spectrometer and Shimadzu SCL-10A LC system. Column: Phenomenex Gemini C18, 5 μm, 50 mm × 4.6 mm i.d., gradient: from 90% water, 10% CH<sub>3</sub>CN, 0.05%TFA, 5 min to 5% water, 95% CH<sub>3</sub>CN, 0.05% TFA in 5 min, UV detection: 254 nm. All targets compounds were >95% pure.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Molecular Modeling</h3><div class="NLM_p last">To model compound <b>68</b> in the NS<sub>3</sub>/NS<sub>4A</sub> protease active site, the crystal structure of compound <b>1</b> bound to NS<sub>3</sub>/NS<sub>4A</sub> protease (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OBO">2OBO</a>) was used as a template upon which the P<sub>1</sub> and P<sub>4</sub> side chains and terminal caps corresponding to <b>68</b> were built. From the crystal structure, the backbone atoms form a network of hydrogen bonds with the protein and therefore predefine the backbone orientation of the compounds. The side chain atoms was energy minimized for 500 steps, followed by another 500 steps of minimization of the whole inhibitor molecule. SYBYL (Tripos, Inc.) molecular modeling package was used in model building and optimization.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Phenylmethyl 1-[[[[1(<i>S</i>)-[[(1<i>R</i>,5<i>S</i>)-2(<i>S</i>)-[[[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]amino]carbonyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]carbonyl]-2,2-dimethylpropyl]amino]carbonyl]amino]cyclohexan Carboxylate (<b>20</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 and 8.34 (d, <i>J</i> = 6.93 and 7.56 Hz, 1H), 8.02 (d, <i>J</i> = 7.88 Hz, 1H), 7.75 (bs, 1H), 7.35−7.30 (m, 5H), 6.47 (bs, 1H), 6.20 (dd, <i>J</i> = 10.08 and 16.07 Hz, 1H), 5.12−5.08 (m, 1H), 5.06 (d, <i>J</i> = 12.92 Hz, 1H), 4.94 (dd, <i>J</i> = 4.72 and 12.92 Hz, 1H), 4.33 (s, 1H), 4.18 (t, <i>J</i> = 8.19 Hz, 1H), 3.88 (t, <i>J</i> = 9.77 Hz, 1H), 3.78−3.73 (m, 1H),1.96 (d, <i>J</i> = 11.03 Hz, 1H), 1.82 (d, <i>J</i> = 12.29 Hz, 1H), 1.71−1.17 (m, 12H), 0.99 (d, <i>J</i> = 11.35 Hz, 3H), 0.93−0.84 (m, 10H), 0.77 (d, <i>J</i> = 12.92 Hz, 3H), 0.43−0.35 (m, 2H), 0.12−0.009 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.47, 197.92, 175.47, 171.82, 171.55, 171.52, 171.32, 163.78, 163.49, 157.63, 157.57, 137.30, 129.11, 128.56, 128.31, 128.30, 128.28, 66.32, 60.20, 59.96, 58.09, 57.76, 57.68, 55.02, 48.34, 35.85, 35.16, 35.14, 33.94, 32.55, 31.56, 31.45, 27.67, 27.58, 27.13, 27.11, 26.97, 26.93, 25.69, 21.62, 21.52, 19.33, 19.30, 13.32, 13.24, 8.75, 8.55, 5.90, 5.21, 4.90. HRMS calcd for C<sub>36</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>, 666.3867 (M + H)<sup>+</sup>; found, 666.3844.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> 3-Thienylmethyl 1-[[[[1(<i>S</i>)-[[(1<i>R</i>,5<i>S</i>)-2(<i>S</i>)-[[[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]amino]carbonyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]carbonyl]-2,2-dimethylpropyl]amino]carbonyl]amino]cyclohexanecarboxylate (<b>21</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 and 8.35 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 8.00 (d, <i>J</i> = 8.51 Hz, 1H), 7.75 (bs, 1H), 7.49−7.44 (m, 2H), 7.05−7.04 (m, 1H), 6.46 (bs, 1H), 6.20 (dd, <i>J</i> = 10.09 and 16.39 Hz, 1H), 5.15−5.02 (m, 2H), 4.96−4.95 and 4.93−4.92 (m, 1H), 4.33 (bs, 1H), 4.17 (t, <i>J</i> = 9.45 Hz, 1H), 3.89−3.85 (m, 1H), 3.78−3.72 (m, 1H), 1.98−1.91 (m, 1H), 1.82−1.79 (m, 1H), 1.72−1.13 (m, 13H), 0.99−0.97 (m, 3H), 0.89 (bs, 9H), 0.77−0.75 (m, 3H), 0.39−0.38 (m, 2H), 0.10−0.01 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.47, 197.92, 175.41, 171.81, 171.51, 171.31, 163.78, 163.48, 157.65, 157.60, 138.20, 128.09, 127.26, 124.18, 62.08, 60.21, 59.97, 58.11, 57.77, 57.70, 55.02, 48.35, 35.87, 35.17, 33.88, 32.59, 31.57, 31.45, 27.69, 27.60, 27.12, 26.98, 26.93, 25.69, 21.63, 21.54, 19.34, 13.31, 13.23, 8.75, 8.54, 5.90, 5.23, 4.90. HRMS calcd for C<sub>34</sub>H<sub>50</sub>N<sub>5</sub>O<sub>7</sub>S, 672.3431 (M + H)<sup>+</sup>; found, 672.3437.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[3,3-dimethyl-1-<i>oxo</i>-2(<i>S</i>)-[[[[1-[(phenylmethoxy)methyl]cyclohexyl]amino]carbonyl]amino]butyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-Carboxamide (<b>26</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 and 8.17 (d, <i>J</i> = 7.25 and 7.25 Hz, 1H), 8.02 (d, <i>J</i> = 17.34 Hz, 1H), 7.76(bs, 1H), 7.35−7.27 (m, 5H), 6.15 (t, <i>J</i> = 8.82 Hz, 1H), 5.79(bs, 1H), 4.99−4.95 and 4.88−4.84 (m, 1H), 4.43 (bs, 1H), 4.28 (d, <i>J</i> = 5.04 Hz, 1H), 4.17 (t, <i>J</i> = 6.62 Hz, 1H), 4.02−3.89 (m, 2H), 3.75 (d, <i>J</i> = 12.29 Hz, 1H), 3.53 (d, <i>J</i> = 8.82 Hz, 1H), 3.46 (d, <i>J</i> = 9.14 Hz, 1H), 2.05−1.07 (m, 21H), 1.00 (d, <i>J</i> = 5.99 Hz, 3H), 0.91(s, 9H), 0.87(d, <i>J</i> = 14.81 Hz, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.65, 197.98, 173.72, 171.86, 171.80, 171.61, 171.60, 163.89, 163.69, 158.03, 157.94, 139.76, 132.43, 130.03, 129.55, 129.03, 129.09, 100.16, 75.93, 73.34, 72.01, 60.34, 60.26, 59.98, 57.62, 57.54, 55.17, 54.33, 52.97, 52.74, 48.28, 37.61, 37.55, 37..39, 35.05, 33.07, 33.00, 32.78, 32.08, 31.50, 31.41, 29.87, 28.80, 28.66, 28.49, 28.34, 28.27, 27.22, 26.98, 26.80, 26.26, 25.37, 22.86, 21.60, 21.52, 19.74, 19.35, 18.73, 18.60, 13.40, 13.34.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 2-Furanylmethyl 1-[[[[1(<i>S</i>)-[[(1<i>R</i>,5<i>S</i>)-2(<i>S</i>)-[[[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]amino]carbonyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]carbonyl]-2,2-dimethylpropyl]amino]carbonyl]amino]cyclohexanecarboxylate (<b>28</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 and 8.32 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 8.01 (d, <i>J</i> = 7.88 Hz, 1H), 7.74(bs, 1H), 7.62 (bs, 1H), 6.44 (d, <i>J</i> = 6.93 Hz, 2H), 6.16 (dd, <i>J</i> = 10.08, 16.39 Hz, 1H), 5.11−5.07 and 5.06−5.02 (m, 1H), 4.96−4.87(m, 2H), 4.32 (s, 1H), 4.15 (t, <i>J</i> = 8.82 Hz, 1H), 3.86 (t, <i>J</i> = 10.71 Hz, 1H), 3.77−3.71 (m, 2H), 1.90−1.74 (m, 1H), 1.71−1.15 (m, 14H), 1.00 (d, <i>J</i> = 9.77 Hz, 3H), 0.88 (bs, 9H), 0.80 (d, <i>J</i> = 13.24 Hz, 3H), 0.41−0.37 (m, 2H), 0.12−0.01 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.47, 197.90, 175.18, 171.82, 171.53, 171.49, 171.27, 163.77, 163.48, 157.53, 157.46, 150.31, 144.29, 111.48, 111.14, 60.20, 59.95, 58.65, 58.11, 57.64, 57.56, 55.01, 54.98, 48.32, 35.85, 35.11, 35.16, 33.88, 32.57, 32.53, 31.55, 31.44, 27.65, 27.55, 27.08, 27.07, 26.98, 26.82, 25.64, 21.59, 21.49, 19.33, 19.30, 13.30, 13.22, 8.73, 8.53, 5.89, 5.21, 4.90.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyll)-2,3-dioxopropyl]-3-[3,3-dimethyl-1-<i>oxo</i>-2(<i>S</i>)-[[[[1-[[(phenylmethyl)amino]carbonyl]cyclohexyl]amino]carbonyl]amino]butyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>29</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 and 8.33 (d, <i>J</i> = 6.62 and 10.71 Hz, 1H), 8.02 (d, <i>J</i> = 9.14 Hz, 1H), 7.93 (bs, 1H), 7.74 (s, 1H), 7.24 (m, 5H), 6.54-.6.45 (m, 1H), 6.20 (s, 1H), 5.11−5.06 and 5.05−5.01 (m, 1H), 4.31 (s, 1H), 4.29 (d, <i>J</i> = 6.62 Hz, 1H), 4.24 (t, <i>J</i> = 9.14 Hz, 1H), 4.20−4.13 (m, 1H), 3.91−3.74 (m, 2H), 2.05 (d, <i>J</i> = 14.50 Hz, 1H), 1.86 (d, <i>J</i> = 9.45 Hz, 1H), 1.71−1.14 (m, 12H), 0.97−0.88 (m, 13H), 0.74 (d, <i>J</i> = 12.61 Hz, 3H), 0.43−0.36 (m, 2H), 0.17−0.02 (m, 2H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 1-[[[[1(<i>S</i>)-[[(1<i>R</i>,5<i>S</i>)-2(<i>S</i>)-[[[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]amino]carbonyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]carbonyl]-2,2-dimethylpropyl]amino]carbonyl]amino]cyclohexanecarboxylate (<b>30</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.39 and 8.32 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 8.01 (d, <i>J</i> = 7.25 Hz, 1H), 7.75(bs, 1H), 6.30 (d, <i>J</i> = 4.09 Hz, 2H), 6.20 (d, <i>J</i> = 10.08 Hz, 1H), 5.11−5.08 and 5.07−5.03 (m, 1H), 4.33 (s, 1H), 4.24−4.15 (m, 1H), 3.91−3.84 (m, 1H), 3.80−3.71 (m, 1H), 1.96−1.93 (m, 1H), 1.81 (d, <i>J</i> = 12.61 Hz, 1H), 1.70−1.11 (m, 12H), 1.01−0.99 (m, 3H), 0.95−0.85 (m, 10H), 0.81−0.77 (m, 3H), 0.47−0.35 (m, 2H), 0.14−0.02 (m, 2H). HRMS calcd for C<sub>29</sub>H<sub>46</sub>N<sub>5</sub>O<sub>7</sub>, 576.3397 (M + H)<sup>+</sup>; found, 576.3403.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[3,3-dimethyl-1-<i>oxo</i>-2(<i>S</i>)-[[[[1-[[(phenylsulfonyl)amino]carbonyl]cyclohexyl]amino]carbonyl]amino]butyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>31</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 and 8.34 (d, <i>J</i> = 7.25 and 7.56 Hz, 1H), 8.02 (d, <i>J</i> = 11.35 Hz, 3H), 7.88 (bs, 1H), 7.79−7.74 (m, 2H), 7.59 (t, <i>J</i> = 10.40 Hz, 1H), 6.63−6.58 (m, 1H), 6.54 (s, 1H), 6.16 (s, 1H), 5.12−5.08 and 5.06−5.02 (m, 1H), 4.34 (bs, 1H), 4.25 (dd, <i>J</i> = 6.62, 9.77 Hz, 1H), 3.87−3.74 (m, 2H), 2.12−2.08 (m, 1H), 2.02−1.98 (m, 1H), 1.85−1.13 (m, 13H), 1.01 (d, <i>J</i> = 10.71 Hz, 3H), 0.91 (s, 9H), 0.80 (d, <i>J</i> = 11.66 Hz, 3H), 0.47−0.36 (m, 2H), 0.12−0.01 (m, 2H). HRMS calcd for C<sub>35</sub>H<sub>51</sub>N<sub>6</sub>O<sub>8</sub>S, 714.8880 (M + H)<sup>+</sup>; found, 714.8892.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Benzyl 2-(3-((2<i>S</i>)-1-((1<i>R</i>,2<i>S</i>,5<i>S</i>)-2-(4-Amino-1-cyclopropyl-3,4-dioxobutan-2-yl)carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl)-3,3-dimethyl-1-oxobutan-2-yl)ureido)-2-methylpropanoate (<b>33</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 −7.60 (m, 1H), 7.05 (s, 1H), 6.95 (s, 1H), 5.85 (d, <i>J</i> = 9.85 Hz, 1H), 5.62−5.56 (m, 1H), 5.17−5.02 (m, 3H), 4.46−4.37 (m, 2H), 4.13−4.00 (m, 2H), 3.84−3.74 (m, 1H), 2.48 (s, 1H), 1.89−1.64 (m, 2H), 1.58−1.37 (m, 5H), 1.27−1.20 (m, 1H), 1.01−0.78 (m, 20H), 0.75−0.64 (m, 1H), 0.40 (t, <i>J</i> = 7.07 Hz, 2H), 0.13−0.05 (m, 2H). LCMS for C<sub>33</sub>H<sub>47</sub>N<sub>5</sub>O<sub>7</sub>: 626.10 (M + H)<sup>+</sup>, purity 98.7%.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (2<i>R</i>)-Benzyl 2-(3-((2<i>S</i>)-1-((1<i>R</i>,2<i>S</i>,5<i>S</i>)-2-(4-Amino-1-cyclopropyl-3,4-dioxobutan-2-yl)carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl)-3,3-dimethyl-1-oxobutan-2-yl)ureido)-2,3-dimethylbutanoate (<b>36</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.34 (s, 5H), 6.96 (s, 1H), 6.89 (s, 1H), 6.81 (s, 1H), 5.51−5.33 (m, 1H), 5.23 (s, 2H), 5.15 (d, <i>J</i> = 12.64 Hz, 1H), 5.03 (d, <i>J</i> = 12.64 Hz, 1H), 4.44−4.34 (m, 2H), 4.05−3.97 (m, 1H), 3.83−3.73 (m, 1H), 3.82−3.67 (m, 2H), 3.66−3.60 (m, 1H), 2.19−2.07 (m, 1H), 1.97−1.78 (m, 1H), 1.70−1.54 (m, 2H), 1.52−1.43 (m, 2H), 1.05−0.85 (m, 17H), 0.84−0.63 (m, 3H), 0.49−0.37 (m, 2H), 0.17−0.07 (m, 2H). LCMS for C<sub>35</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>: 654.50 (M + H)<sup>+</sup>, purity 98.9%.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (2<i>S</i>)-Benzyl 2-(3-((2<i>S</i>)-1-((1<i>R</i>,2<i>S</i>,5<i>S</i>)-2-(4-Amino-1-cyclopropyl-3,4-dioxobutan-2-yl)carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl)-3,3-dimethyl-1-oxobutan-2-yl)ureido)-2,3-dimethylbutanoate (<b>37</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.62 (d, <i>J</i> = 5.09 Hz, 1H), 7.32 (s, 5H), 6.93 (s, 1H), 6.79 (s, 1H), 6.23 (s, 1H), 5.33 (d, <i>J</i> = 6.72 Hz, 1H), 5.13 (s, 2H), 4.44 (d, <i>J</i> = 12.11 Hz, 2H), 4.11 (d, <i>J</i> = 10.35 Hz, 1H), 3.83−3.73 (m, 1H), 3.69 (s, 1H), 2.21−2.03 (m, 1H), 1.89−1.66 (m, 2H), 1.61−1.40 (m, 5H), 1.25 (s, 1H), 1.04−0.68 (m, 20H), 0.43 (d, <i>J</i> = 8.22 Hz, 2H), 0.14−0.02 (m, 2H). LCMS for C<sub>35</sub>H<sub>51</sub>N<sub>5</sub>O<sub>7</sub>: 654.20 (M + H)<sup>+</sup>, purity 96.5%.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[3,3-dimethyl-2(<i>S</i>)-[[[[2-methyl-1(<i>S</i>)-[[(phenylsulfonyl)amino]carbonyl]propyl]amino]carbonyl]amino]butyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>44</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 and 8.34 (d, <i>J</i> = 6.62 and 7.56 Hz, 1H), 8.01(d, <i>J</i> = 10.40 Hz, 1H), 7.86 (d, <i>J</i> = 7.56 Hz, 3H), 7.74 (bs, 1H), 7.61 (bs, 1H),7.55 (d, <i>J</i> = 6.93 Hz, 2H), 6.30 (dd, <i>J</i> = 10.40, 13.87 Hz, 1H), 6.23 (d, <i>J</i> = 8.52 Hz, 1H), 5.10−5.06 and 5.04−5.00 (m, 1H), 4.29 (s, 1H), 4.12 (t, <i>J</i> = 9.14 Hz, 1H), 3.99 (bs, 1H), 3.86 (t, <i>J</i> = 10.40 Hz, 1H), 3.76−3.71 (m, 1H), 1.88−1.82 (m, 1H), 1.70−1.52 (m, 1H), 1.44−1.23 (m, 4H), 1.00 (d, <i>J</i> = 10.40 Hz, 3H), 0.83 (s, 9H), 0.79 (d, <i>J</i> = 13.24 Hz, 3H), 0.66 (d, <i>J</i> = 5.35 Hz, 3H), 0.54 (d, <i>J</i> = 6.62 Hz, 3H), 0.39−0.36 (m, 2H), 0.12−0.005 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.47, 197.89, 171.87, 171.59, 171.47, 171.27, 163.81, 163.50, 158.41, 158.39, 129.43, 128.09, 60.23, 59.99, 59.23, 58.20, 58.09, 54.98, 54.96, 48.28, 35.83, 35.07, 35.05, 31.86, 31.56, 31.45, 27.78, 27.69, 27.22, 27.19, 26.99, 26.95, 19.86, 19.36, 19.34, 17.75, 13.46, 13.41, 8.74, 8.53, 5.90, 5.21, 4.90. HRMS calcd for C<sub>33</sub>H<sub>49</sub>N<sub>6</sub>O<sub>8</sub>S, 689.8500 (M + H)<sup>+</sup>; found, 689.8591.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1(<i>S</i>)-benzoyl-2-methylpropyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>46</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 and 8.36 (d, <i>J</i> = 6.93 and 7.25 Hz, 1H), 8.02 (d, <i>J</i> = 9.77 Hz, 1H), 7.97 (d, <i>J</i> = 8.19 Hz, 2H), 7.75(bs, 1H), 7.64 (t, <i>J</i> = 7.56 Hz, 1H), 7.52 (t, <i>J</i> = 7.88 Hz, 2H), 6.58 (d, <i>J</i> = 8.82 Hz, 1H), 6.39 (<i>J</i> = 9.77 and 13.55 Hz, 1H), 5.17 (dd, <i>J</i> = 5.04 and 8.82 Hz, 1H), 5.13−5.09 and 5.07−5.03 (m, 1H), 4.35 (s, 1H), 4.21 (d, <i>J</i> = 8.19 Hz, 1H), 3.90 (t, <i>J</i> = 10.40 Hz, 1H), 3.80−3.74 (m, 1H), 2.04−1.99 (m, 1H), 1.72−1.56 (m, 1H), 1.47−1.31 (m, 3H), 1.01 (d, <i>J</i> = 9.77 Hz, 3H), 0.90−0.83 (m, 16H), 0.70 (d, <i>J</i> = 9.14 Hz, 3H), 0.42−0.36 (m, 2H), 0.11−0.006 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.00, 198.48, 197.90, 171.83, 171.55, 171.44, 171.24, 163.79, 163.50, 158.55, 158.53, 136.57, 134.23, 129.27, 129.05, 60.25, 60.02, 59.28, 58.17, 58.07, 55.01, 54.98, 48.32, 35.89, 35.17, 35.16, 31.58, 31.47, 31.25, 31.22, 27.77, 27.67, 27.16, 27.13, 26.99, 26.95, 20.49, 19.35, 19.33, 17.66, 13.48, 13.41, 8.74, 8.54, 5.90, 5.21, 4.90. HRMS calcd for C<sub>33</sub>H<sub>48</sub>N<sub>5</sub>O<sub>6</sub>, 611.3672 (M + H)<sup>+</sup>; found, 611.3674.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[3,3-dimethyl-2(<i>S</i>)-[[[[2-methyl-1(<i>R</i>)-([phenylmethyl)propyl]amino]carbonyl]amino]-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>48</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.39 and 8.31 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 8.01 (d, <i>J</i> = 9.14 Hz, 1H), 7.47 (s, 1H), 7.23−7.12 (m, 5H), 5.99−5.94 (m, 2H), 5.11−5.07 and 5.05−5.01 (m, 1H), 4.31 (s, 1H), 4.13 (t, <i>J</i> = 6.93 Hz, 1H), 3.87 (t, <i>J</i> = 10.08 Hz, 1H), 3.76−3.70 (m, 1H), 3.68−3.63 (m, 1H), 2.67 (dd, <i>J</i> = 4.72 and 13.87 Hz, 2H), 1.71−1.54 (m, 2H), 1.46−1.23 (m, 3H), 1.00 (d, <i>J</i> = 10.40 Hz, 3H), 0.83 (s, 9H), 0.81−0.76 (m, 10H), 0.43−0.36 (m, 2H), 0.12−0.01 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.47, 197.92, 171.85, 171.72, 171.56, 171.52, 163.78, 163.48, 158.54, 158.49, 140.52, 129.83, 128.82, 126.55, 60.17, 59.91, 57.78, 57.70, 55.87, 55.86, 54.99, 54.96, 48.26, 48.23, 39.45, 39.43, 35.85, 35.13, 35.11, 31.92, 31.55, 31.45, 27.68, 27.58, 27.14, 27.12, 26.99, 26.94, 20.39, 19.32, 19.29, 17.66, 13.38, 13.32, 8.74, 8.54, 5.90, 5.21, 4.90. HRMS calcd for C<sub>33</sub>H<sub>49</sub>NaN<sub>5</sub>O<sub>5</sub>, 618.3631 (M + Na)<sup>+</sup>; found, 618.3655.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[3,3-dimethyl-1-<i>oxo</i>-2(<i>S</i>)-[[[[1(<i>S</i>)-(2-pyridinylcarbonyl)-2-methylpropyl]amino]carbonyl]amino]butyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>52</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76 (t, <i>J</i> = 4.72 Hz, 1H), 8.03 (d, <i>J</i> = 7.56 Hz, 2H), 7.98 (t, <i>J</i> = 9.14 Hz, 1H), 7.75−7.68 (m, 2H), 6.55−6.52 (m, 2H), 5.67−5.64 (m, 1H), 5.11−5.08 and 5.06−5.03 (m, 1H), 4.33 (d, <i>J</i> = 3.15 Hz, 1H), 4.16 (t, <i>J</i> = 9.14 Hz, 1H), 3.88 (d, <i>J</i> = 9.45 Hz, 1H), 3.78−3.72 (m, 2H), 2.21−2.14 (m, 1H), 1.73−1.15 (m, 5H), 1.02 (d, <i>J</i> = 9.77 Hz, 3H), 0.92−0.71 (m, 15H), 0.66 (d, <i>J</i> = 6.62 Hz, 3H), 0.41−0.35 (m, 2H), 0.11−0.02 (m, 2H). HRMS calcd for C<sub>32</sub>H<sub>47</sub>N<sub>6</sub>O<sub>6</sub>, 611.3479 (M + H)<sup>+</sup>; found, 611.3522.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[3,3-dimethyl-2(<i>S</i>)-[[[[2-methyl-1(<i>S</i>)-(2-thienylcarbonyl)propyl]amino]carbonyl]amino]-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>53</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 and 8.37 (d, <i>J</i> = 6.62 and 7.56 Hz, 1H), 8.03 (t, <i>J</i> = 4.72 Hz, 3H), 7.75 (bs, 1H),7.26 (t, <i>J</i> = 4.72 Hz, 1H), 6.60 (d, <i>J</i> = 8.51 Hz, 1H), 6.36 (dd, <i>J</i> = 10.08 and 13.87 Hz, 1H), 5.12−5.08 and 5.06−5.02 (m, 1H), 4.93−4.90 (m, 1H), 4.34 (d, <i>J</i> = 3.15 Hz, 1H), 4.18 (t, <i>J</i> = 9.14 Hz, 1H), 3.87 (t, <i>J</i> = 11.35 Hz, 1H), 3.81−3.73 (m, 1H), 2.08−2.03 (m, 1H), 1.72−1.52 (m, 1H), 1.47−1.23 (m, 4H), 1.02 (d, <i>J</i> = 10.40 Hz, 3H), 0.89−0.81 (m, 15H), 0.77 (d, <i>J</i> = 6.93 Hz, 3H), 0.42−0.37 (m, 2H), 0.12−0.01 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.51, 197.89, 193.82, 173.66, 171.82, 171.54, 171.36, 171.19, 163.79, 163.49, 158.42, 158.40, 143.31, 136.23, 134.45, 129.73, 60.65, 60.40, 60.22, 60.01, 58.12, 58.03, 54.98, 48.31, 35.86, 35.22, 35.16, 31.79, 31.75, 31.58, 31.48, 27.73, 27.64, 27.11, 27.05, 27.00, 26.96, 26.88, 20.47, 19.36, 19.33, 18.10, 13.47, 13.43, 8.76, 8.55, 5.91, 5.21, 4.90. HRMS calcd for C<sub>33</sub>H<sub>48</sub>N<sub>5</sub>O<sub>6</sub>S, 616.3169 (M + H)<sup>+</sup>; found, 616.3170.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[3,3-dimethyl-2(<i>S</i>)-[[[[2-methyl-1(<i>S</i>)-(2-thiazolylcarbonyl)propyl]amino]carbonyl]amino]-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>54</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 and 8.36 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 8.27 (d, <i>J</i> = 2.87 Hz, 1H), 8.20 (d, <i>J</i> = 2.83 Hz, 1H), 8.02 (d, <i>J</i> = 9.45 Hz, 1H), 7.75 (bs, 1H), 6.62 (d, <i>J</i> = 8.82 Hz, 1H), 6.42 (dd, <i>J</i> = 9.77 and 13.55 Hz, 1H), 5.32−5.30 (m, 1H), 5.12−5.08 and 5.06−5.02 (m, 1H), 4.34 (d, <i>J</i> = 3.15 Hz, 1H), 4.15 (t, <i>J</i> = 9.14 Hz, 1H), 3.85 (t, <i>J</i> = 10.71 Hz, 1H), 3.77−3.72 (m, 1H), 2.29−2.25 (m, 1H), 1.72−1.53 (m, 1H), 1.47−1.30 (m, 3H), 1.01 (d, <i>J</i> = 9.77 Hz, 3H), 0.94−0.79 (m, 16H), 0.74 (d, <i>J</i> = 6.62 Hz, 3H), 0.43−0.35 (m, 2H), 0.12−0.008 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.50, 197.94, 193.98, 171.83, 171.55, 171.38, 171.18, 165.91, 163.81, 163.49, 158.52, 158.51, 146.22, 129.31, 60.51, 60.21, 60.02, 58.18, 58.10, 55.00, 54.98, 48.30, 35.86, 35.15, 31.58, 31.49, 31.20, 31.18, 27.75, 27.66, 27.18, 27.16, 27.00, 26.96, 20.60, 19.38, 19.35, 17.58, 13.45, 13.38, 8.76, 8.55, 5.91, 5.21, 4.90. HRMS calcd for C<sub>30</sub>H<sub>45</sub>N<sub>6</sub>O<sub>6</sub>S, 617.3121 (M + H)<sup>+</sup>; found, 617.3134.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[[1(<i>S</i>)-(cyclopropylcarbonyl)-2-methylpropyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>55</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 and 8.35 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 8.00 (d, <i>J</i> = 9.77 Hz, 1H), 7.75 (bs, 1H), 6.44 (d, <i>J</i> = 8.83 Hz, 1H), 6.34 (dd, <i>J</i> = 10.08 and 14.18 Hz, 1H), 5.12−5.08 and 5.06−5.02 (m, 1H), 4.36−4.32 (m, 2H), 4.19 (t, <i>J</i> = 9.45 Hz, 1H), 3.90−3.83 (m, 1H), 3.79−3.73 (m, 1H), 2.24−2.11 (m, 2H), 1.73−1.65 (m, 1H), 1.63−1.52 (m, 1H), 1.49−1.39 (m, 2H), 1.36−1.29 (m, 1H), 1.00 (d, <i>J</i> = 10.4 Hz, 3H), 0.90−0.72 (m, 18H), 0.70−0.69 (m, 4H), 0.45−0.29 (m, 2H), 0.15−0.01 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 210.83, 198.46, 197.88, 171.85, 171.56, 171.48, 171.27, 163.8, 163.48, 158.56, 64.61, 60.24, 60.02, 58.13, 58.04, 54.97, 48.30, 35.86, 35.17, 31.56, 31.45, 30.23, 30.21, 27.76, 27.67, 27.17, 26.98, 20.35, 19.36, 18.81, 17.79, 13.44, 11.78, 11.20, 8.73, 8.53, 5.89, 5.20, 4.89. HRMS calcd for C<sub>30</sub>H<sub>48</sub>N<sub>5</sub>O<sub>6</sub>, 574.3604 (M + H)<sup>+</sup>; found, 574.3616.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[3,3-dimethyl-2(<i>S</i>)-[[[[3-methyl-1(<i>S</i>)-(1-methylethyl)-2-oxobutyl]amino]carbonyl]amino]-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>59</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) 8.40 and 8.34 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 8.01 (d, <i>J</i> = 9.14 Hz, 1H), 7.74 (bs, 1H), 6.41 (d, <i>J</i> = 9.14 Hz, 1H), 6.30 (dd, <i>J</i> = 9.77 and 14.18 Hz, 1H), 5.12−5.08 and 5.06−5.02 (m, 1H), 4.33 (d, <i>J</i> = 2.83 Hz, 1H), 4.27 (q, <i>J</i> = 5.35 and 9.14 Hz, 1H), 4.19 (t, <i>J</i> = 9.45 Hz, 1H), 3.88 (d, <i>J</i> = 10.71 Hz, 1H), 3.79−3.73 (m, 1H), 2.82 (p, <i>J</i> = 6.90 Hz, 1H), 2.07−2.00 (m, 1H), 1.71−1.52 (m, 1H), 1.47−1.40 (m, 2H), 1.35−1.30 (m, 1H), 1.01−0.98 (m, 6H), 0.95−0.87 (m, 13H), 0.82−0.79 (m, 6H), 0.69 (d, <i>J</i> = 6.93 Hz, 3H), 0.42−0.36 (m, 2H), 0.14−0.01 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 214.96, 198.47, 197.92, 171.84, 171.55, 171.44, 171.24, 163.80, 163.49, 158.54, 158.52, 62.34, 60.22, 59.99, 58.10, 58.02, 55.00, 54.98, 48.31, 37.84, 35.85, 35.18, 35.17, 29.86, 29.84, 28.53, 27.73, 27.63, 27.16, 27.13, 26.99, 26.95, 20.49, 19.44, 19.35, 19.33, 18.55, 17.90, 13.41, 13.35, 8.76, 8.55, 5.90, 5.21, 4.90. HRMS calcd for C<sub>33</sub>H<sub>59</sub>N<sub>5</sub>O<sub>5</sub>, 576.3761 (M + H)<sup>+</sup>; found, 576.3738.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[[1(<i>S</i>)-cyclohexyl-2-<i>oxo</i>-2-(2-pyridinyl)ethyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2(<i>S</i>)-carboxamide (<b>61</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (d, <i>J</i> = 5.04 Hz, 1H), 8.41 and 8.35 (d, <i>J</i> = 6.93 and 7.56 Hz, 1H), 8.04−7.96 (m, 3H), 7.75 (bs, 1H), 7.70−7.67 (m, 1H), 6.56 (d, <i>J</i> = 9.14 Hz, 1H), 6.44−6.39 (m, 1H), 5.68−5.65 (m, 1H), 5.12−5.08 and 5.07−5.03 (m, 1H), 4.34 (bs, 1H), 4.16 (t, <i>J</i> = 9.45 Hz, 1H), 3.89(t, <i>J</i> = 10.71 Hz, 1H), 3.78−3.72 (m, 1H), 1.80−1.75 (m, 1H), 1.66−1.30 (m, 8H), 1.13−0.83 (m, 22H), 0.41−0.36 (m, 2H), 0.11−0.01 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.69, 198.49, 197.92, 171.85, 171.57, 171.54, 171.32, 163.82, 163.52, 158.51, 158.49, 152.81, 150.12, 138.67, 128.82, 123.00, 60.23, 60.00, 58.40, 58.39, 58.15, 58.05, 55.01, 54.98, 48.28, 35.88, 35.13, 35.11, 31.59, 31.50, 30.69, 27.82, 27.76, 27.69, 27.20, 27.17, 27.02, 26.98, 26.64, 26.56, 26.44, 19.35, 19.33, 13.38, 13.32, 8.74, 8.54, 5.90, 5.21, 4.91. HRMS calcd for C<sub>35</sub>H<sub>51</sub>N<sub>6</sub>O<sub>6</sub>, 651.3870 (M + H)<sup>+</sup>; found, 651.3872.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclopropylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1(<i>S</i>)-cyclohexyl-2-cyclopropyl-2-oxoethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2(<i>S</i>)-carboxamide (<b>62</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 and 8.36 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 8.02 (t, <i>J</i> = 8.82 Hz, 1H), 7.75 (bs, 1H), 6.46 (d, <i>J</i> = 8.82 Hz, 1H), 6.32 (dd, <i>J</i> = 10.08 and 14.50 Hz, 1H), 5.11−5.08 and 5.06−5.02 (m, 1H), 4.33−4.30 (m, 2H), 4.23−4.15 (m, 1H), 3.88 (t, <i>J</i> = 10.71 Hz, 1H), 3.80−3.73 (m, 1H), 2.17−2.10 (m, 1H), 1.83−1.75 (m, 1H), 1.71−1.11 (m, 11H), 1.02−0.97 (m, 5H), 0.94−0.85 (m, 13H), 0.83−0.81 (m, 3H), 0.80−0.75 (m, 2H), 0.47−0.31 (m, 2H), 0.14−0.03 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 210.78, 198.51, 197.90, 171.82, 171.54, 171.46, 171.26, 163.77, 163.50, 158.45, 158.43, 130.23, 115.66, 110.47, 94.63, 64.37, 60.12, 59.93, 58.06, 57.98, 55.01, 48.31, 35.85, 35.24, 35.17, 31.60, 30.41, 28.07, 27.77, 27.63, 27.17, 27.15, 27.09, 27.00, 26.97, 26.62, 26.53, 19.36, 19.32, 18.95, 13.37, 13.32, 13.00, 11.74, 11.34, 8.75, 8.55, 5.91, 5.21, 4.90. HRMS calcd for C<sub>33</sub>H<sub>52</sub>N<sub>5</sub>O<sub>6</sub>, 614.3839 (M + H)<sup>+</sup>; found, 614.3845.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (1<i>R</i>,5<i>S</i>)-3-[2(<i>S</i>)-[[[[1(<i>S</i>)-(Cyclopropylcarbonyl)-2-methylpropyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-<i>N</i>-[1-[1,2-dioxo-2-(propenylamino)ethyl]butyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (<b>63</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.87 and 8.81 (t, <i>J</i> = 6.0 Hz, 1H), 8.39 and 8.34 (d, <i>J</i> = 6.93 and 7.25 Hz, 1H), 6.44 (d, <i>J</i> = 8.82 Hz, 1H), 6.33 (t, <i>J</i> = 10.08 Hz, 1H), 5.83−5.75 (m, 1H), 5.12 (d, <i>J</i> = 1.57 Hz, 1H), 5.09−5.04 (m, 1H), 5.00−4.96 and 4.89−4.85 (m, 1H), 4.35 (q, <i>J</i> = 4.72 and 8.82 Hz, 1H), 4.30 (d, <i>J</i> = 6.93 Hz, 1H), 4.22−4.16 (m, 1H), 3.87 (d, <i>J</i> = 10.08 Hz, 1H), 3.79−3.68 (m, 3H), 2.18−2.15 (m, 2H), 1.74−1.65 (m, 1H), 1.55−1.23 (m, 5H), 1.01 (d, <i>J</i> = 9.45 Hz, 3H), 0.93−0.75 (m, 22H), 0.71 (d, <i>J</i> = 6.93 Hz, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 210.82, 198.22, 197.60, 171.88, 171.79, 171.40, 171.24, 162.02, 161.64, 158.59, 158.56, 135.05, 135.00, 116.46, 116.36, 64.61, 60.23, 59.98, 58.07, 54.37, 48.29, 41.70, 35.16, 32.51, 32.47, 31.58, 31.55, 30.23, 30.21, 27.83, 27.75, 27.18, 26.99, 26.96, 20.59, 20.37, 19.57, 19.43, 19.36, 18.81, 17.81, 17.58, 14.45, 14.33, 13.44, 13.38, 11.76, 11.19. HRMS calcd for C<sub>32</sub>H<sub>52</sub>N<sub>5</sub>O<sub>6</sub>, 602.3918 (M + H)<sup>+</sup>; found, 602.3940.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (1<i>R</i>,5<i>S</i>)-3-[2(<i>S</i>)-[[[(1(<i>S</i>)-Cyclohexyl-2-cyclopropyl-2-oxoethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-<i>N</i>-[1-[1,2-dioxo-2-(2-propenylamino)ethyl]butyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2(<i>S</i>)-carboxamide (<b>64</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.88 and 8.82 (t, <i>J</i> = 5.99 Hz, 1H), 8.40 and 8.35 (d, <i>J</i> = 6.62 and 7.25 Hz, 1H), 6.46 (d, <i>J</i> = 8.50 Hz, 1H), 6.31 (t, <i>J</i> = 10.40 Hz, 1H), 5.83−5.76 (m, 1H), 5.12−5.04 (m, 2H), 5.01−4.96 and 4.89−4.85 (m, 1H), 4.33−4.29 (m, 2H), 4.19−4.16 (m, 1H), 3.87 (t, <i>J</i> = 10.08 Hz, 1H), 3.79−3.71 (m, 3H), 2.17−2.12 (m, 1H), 1.84−1.76 (m, 1H), 1.73−1.03 (m, 16H), 1.07−0.97 (m, 5H), 0.94−0.75 (m, 17H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 210.77, 198.22, 197.61, 171.96, 171.79, 171.41, 171.25, 162.02, 161.64, 158.46, 158.43, 135.05, 135.00, 116.46, 116.36, 64.37, 60.22, 59.96, 58.00, 54.37, 48.28, 41.70, 35.17, 32.52, 32.47, 31.58, 31.55, 30.41, 28.08, 27.83, 27.74, 27.16, 27.00, 26.97, 26.63, 26.54, 19.57, 19.44, 19.35, 18.95, 14.45, 13.35, 13.29, 11.71, 11.32. HRMS calcd for C<sub>35</sub>H<sub>55</sub>N<sub>5</sub>NaO<sub>6</sub>, 664.4050 (M + Na)<sup>+</sup>; found, 664.4059.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (1<i>R</i>,2<i>S</i>,5<i>S</i>)-3-((<i>S</i>)-2-(3-((<i>S</i>)-1-Cyclohexyl-2-cyclopropyl-2-oxoethyl)ureido)-3,3-dimethylbutanoyl)-<i>N</i>-(1-(cyclopropylamino)-1,2-dioxohept-6-yn-3-yl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide (<b>68</b>)</h3><div class="NLM_p last">The product was isolated as a mixture of two diastereomers (∼1:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.8.72 (d, <i>J</i> = 5.13 Hz, 1H), 8.44(d, <i>J</i> = 7.32 Hz, 1H), 6.46−6.41 (m, 2H), 6.31−6.24 (m, 2H), 5.00−4.92 (m, 1H), 4.33−4.26 (m, 2H), 4.25 (s, 1H), 4.23−4.18 (m, 1H), 4.14 (d, <i>J</i> = 9.52 Hz, 2H), 3.84 (d, <i>J</i> = 10.25 Hz, 2H), 3.81−3.69 (m, 2H), 2.78 (s, 1H), 2.76−2.68 (m, 1H), 2.34−2.18 (m, 2H), 2.17−2.08 (m, 2H), 2.00−1.90 (m, 1H), 1.83−1.73 (m, 2H), 1.71−1.48 (m, 4H), 1.44−1.38 (m, 1H), 1.36−1.27 (m, 1H), 1.25−1.05 (m, 2H), 1.03−0.92 (m, 4H), 0.88 (s, 9H), 0.82−078 (m, 4H), 0.66−0.60 (m, 2H), 0.58−0.51 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 210.77, 197.40, 172.07, 171,27, 162.92, 158.45, 84.15, 72.73, 60.06, 57.99, 54.18, 48.27, 40.99, 40.82, 40.65, 35.16, 31.50, 30.41, 29.96, 28.08, 27.88, 27.20, 26.98, 26.63, 26.54, 23.33, 20.42, 19.39, 18.95, 15.58, 13.34, 11.73, 11.34, 6.26. LCMS for C<sub>36</sub>H<sub>54</sub>N<sub>5</sub>O<sub>3</sub>: 652.3 (M + H)<sup>+</sup>, purity 96.5%.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stéphane L. Bogen</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#95e6e1f0e5fdf4fbf0bbf7faf2f0fbd5e6e5f6fae7e5bbf6faf8"><span class="__cf_email__" data-cfemail="abd8dfcedbc3cac5ce85c9c4cccec5ebd8dbc8c4d9db85c8c4c6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weidong Pan</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sumei Ruan</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Latha G. Nair</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashok Arasappan</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Bennett</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin X. Chen</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edwin Jao</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srikanth Venkatraman</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bancha Vibulbhan</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rong Liu</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuo-Chi Cheng</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhuyan Guo</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao Tong</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anil K. Saksena</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viyyoor Girijavallabhan</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. George Njoroge</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm801632a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 17 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span>World Health Organization Fact Sheet Number 164; <span class="NLM_month">October</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization+Fact+Sheet+Number+164%3B+October%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Health%2520Organization%2520Fact%2520Sheet%2520Number%2520164%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wasley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Epidemiology of hepatitis C: geographic differences and temporal trends</span> <span class="citation_source-journal">Semin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1055%2Fs-2000-9506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10895428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1-16&author=A.+Wasleyauthor=M.+J.+Alter&title=Epidemiology+of+hepatitis+C%3A+geographic+differences+and+temporal+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of hepatitis C: geographic differences and temporal trends</span></div><div class="casAuthors">Wasley A; Alter M J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in liver disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn">0272-8087</span>.
    </div><div class="casAbstract">Hepatitis C Virus (HCV) infection appears to be endemic in most parts of the world, with an estimated overall prevalence of 3%.  However, there is considerable geographic and temporal variation in the incidence and prevalence of HCV infection.  Using age-specific prevalence data, at least three distinct transmission patterns can be identified.  In countries with the first pattern (e.g., United States, Australia), most infections are found among persons 30-49 years old, indicating that the risk for HCV infection was greatest in the relatively recent past (10-30 years ago) and primarily affected young adults.  In countries with the second pattern (e.g., Japan, Italy), most infections are found among older persons, consistent with the risk for HCV infection having been greatest in the distant past.  In countries with the third pattern (e.g., Egypt), high rates of infection are observed in all age groups, indicating an ongoing high risk for acquiring HCV infection.  In countries with the first pattern, injection drug use has been the predominant risk factor for HCV infection, whereas in those with the second or third patterns, unsafe injections and contaminated equipment used in healthcare-related procedures appear to have played a predominant role in transmission.  Much of the variability between regions can be explained by the frequency and extent to which different risk factors have contributed to the transmission of HCV.  Because different strategies are required to interrupt different patterns of HCV transmission, determining the epidemiology of HCV infection in areas where that information has not yet been assessed is critical for developing appropriate prevention programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSp2wQyhQIHd7HHuJhbyicZfW6udTcc2eaunvlm8HIM3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D&md5=7c7736c5229d0104950eace9fa66a3fe</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-9506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-9506%26sid%3Dliteratum%253Aachs%26aulast%3DWasley%26aufirst%3DA.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DEpidemiology%2520of%2520hepatitis%2520C%253A%2520geographic%2520differences%2520and%2520temporal%2520trends%26jtitle%3DSemin.%2520Liver%2520Dis.%26date%3D2000%26volume%3D20%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brown, R. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaglio, P. J.</span><span> </span><span class="NLM_article-title">Scope of worldwide hepatitis C problem</span> <span class="citation_source-journal">Liver Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">S10</span><span class="NLM_x">–</span> <span class="NLM_lpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=S10-S13&author=R.+S.+Brownauthor=P.+J.+Gaglio&title=Scope+of+worldwide+hepatitis+C+problem"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26aulast%3DGaglio%26aufirst%3DP.%2BJ.%26atitle%3DScope%2520of%2520worldwide%2520hepatitis%2520C%2520problem%26jtitle%3DLiver%2520Transplant.%26date%3D2003%26volume%3D9%26spage%3DS10%26epage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Feld, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span> </span><span class="NLM_article-title">Mechanism of action of interferon and ribavirin in treatment of hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=967&author=J.+J.+Feldauthor=J.+H.+Hoofnagle&title=Mechanism+of+action+of+interferon+and+ribavirin+in+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeld%26aufirst%3DJ.%2BJ.%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26atitle%3DMechanism%2520of%2520action%2520of%2520interferon%2520and%2520ribavirin%2520in%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cuthbert, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C: Progress and Problems</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=7834603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1994&pages=505-532&author=J.+A.+Cuthbert&title=Hepatitis+C%3A+Progress+and+Problems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C: progress and problems</span></div><div class="casAuthors">Cuthbert J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-32</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV), a single-stranded RNA virus, is the major cause of posttransfusion hepatitis.  HCV isolates differ in nucleotide and amino acid sequences.  Nucleotide changes are concentrated in hypervariable regions and may be related to immune selection.  In most immunocompetent persons, HCV infection is diagnosed serologically, using antigens from conserved regions.  Amplification of RNA may be necessary to detect infection in immunosuppressed patients.  Transmission by known parenteral routes is frequent; other means of spread are less common and may represent inapparent, percutaneous dissemination.  Infection can lead to classical acute hepatitis, but most infected persons have no history of acute disease.  Once infected, most individuals apparently remain carriers of the virus, with varying degrees of hepatocyte damage and fibrosis ensuing.  Chronic hepatitis may lead to cirrhosis and hepatocellular carcinoma.  However, disease progression varies widely, from less than 2 years to cirrhosis in some patients to more than 30 years with only chronic hepatitis in others.  Determinants important in deciding outcome are unknown.  Alpha interferon, which results in sustained remission in selected patients, is the only available therapy.  Long-term benefits from such therapy have not been demonstrated.  Prevention of HCV infection by vaccination is likely to be challenging if ongoing viral mutation results in escape from neutralization and clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXDQuuyW-2sDEC-75aqa5AfW6udTcc2eae84NVRIvnGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D&md5=b4434f7061f607052197da39e1916b0a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuthbert%26aufirst%3DJ.%2BA.%26atitle%3DHepatitis%2520C%253A%2520Progress%2520and%2520Problems%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1994%26volume%3D7%26spage%3D505%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cohen, J.</span><span> </span><span class="NLM_article-title">The Scientific Challenge of Hepatitis C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=26-30&author=J.+Cohen&title=The+Scientific+Challenge+of+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DThe%2520Scientific%2520Challenge%2520of%2520Hepatitis%2520C%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Alter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszon-Moran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nainan, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, H. S.</span><span> </span><span class="NLM_article-title">The Prevalence of Hepatitis C Virus Infection in The United States, 1988 through 1994</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1056%2FNEJM199908193410802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10451460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=556-562&author=M.+J.+Alterauthor=D.+Kruszon-Moranauthor=O.+V.+Nainanauthor=G.+M.+McQuillanauthor=F.+Gaoauthor=L.+A.+Moyerauthor=R.+A.+Kaslowauthor=H.+S.+Margolis&title=The+Prevalence+of+Hepatitis+C+Virus+Infection+in+The+United+States%2C+1988+through+1994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</span></div><div class="casAuthors">Alter M J; Kruszon-Moran D; Nainan O V; McQuillan G M; Gao F; Moyer L A; Kaslow R A; Margolis H S</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">556-62</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population-based serologic studies are needed to estimate the prevalence of the infection and to develop and evaluate prevention efforts.  METHODS:  We performed tests for antibody to HCV (anti-HCV) on serum samples from 21,241 persons six years old or older who participated in the third National Health and Nutrition Examination Survey, conducted during 1988 through 1994.  We determined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of sequencing.  RESULTS:  The overall prevalence of anti-HCV was 1.8 percent, corresponding to an estimated 3.9 million persons nationwide (95 percent confidence interval, 3.1 million to 4.8 million) with HCV infection.  Sixty-five percent of the persons with HCV infection were 30 to 49 years old.  Seventy-four percent were positive for HCV RNA, indicating that an estimated 2.7 million persons in the United States (95 percent confidence interval, 2.4 million to 3.0 million) were chronically infected, of whom 73.7 percent were infected with genotype 1 (56.7 percent with genotype 1a, and 17.0 percent with genotype 1b).  Among subjects 17 to 59 years of age, the strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior.  Other factors independently associated with infection included poverty, having had 12 or fewer years of education, and having been divorced or separated.  Neither sex nor racial-ethnic group was independently associated with HCV infection.  CONCLUSIONS:  In the United States, about 2.7 million persons are chronically infected with HCV.  People who use illegal drugs or engage in high-risk sexual behavior account for most persons with HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTwajewlRkP_tos8R3JUhXfW6udTcc2eae84NVRIvnGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D&md5=d36f80ca56095fcd3cb19271f9e80dca</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1056%2FNEJM199908193410802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199908193410802%26sid%3Dliteratum%253Aachs%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26aulast%3DKruszon-Moran%26aufirst%3DD.%26aulast%3DNainan%26aufirst%3DO.%2BV.%26aulast%3DMcQuillan%26aufirst%3DG.%2BM.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DMoyer%26aufirst%3DL.%2BA.%26aulast%3DKaslow%26aufirst%3DR.%2BA.%26aulast%3DMargolis%26aufirst%3DH.%2BS.%26atitle%3DThe%2520Prevalence%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%2520in%2520The%2520United%2520States%252C%25201988%2520through%25201994%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D556%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Emerging therapies for Hepatitis C infection</span> <span class="citation_source-journal">Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1517%2F14728214.6.1.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=15989494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Srtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=13-42&author=B.+W.+Dymock&title=Emerging+therapies+for+Hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging therapies for hepatitis C virus infection</span></div><div class="casAuthors">Dymock, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Drugs</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-42</span>CODEN:
                <span class="NLM_cas:coden">EMDRFV</span>;
        ISSN:<span class="NLM_cas:issn">1361-9195</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 172 refs.  Hepatitis C virus (HCV) has infected millions of people worldwide and has emerged as a global health crisis.  The currently available therapy is interferon (IFN) either alone or in combination with ribavirin.  However, the disappointing efficacy of IFN has led to the considerable need for improved treatments and a no. of new therapies are under evaluation in clin. trials.  These include pegylated IFNs, which have altered physiochem. characteristics allowing once-weekly dosing.  Combination of pegylated IFN with ribavirin should further improve sustained response rates.  However, not all patients are successfully treated with IFNs, particularly those infected with genotype 1 of the virus, and it is likely that potent, specific drugs will be required.  The majority of new approaches currently trying to combat this viral disease are aimed at inhibition of viral targets.  Most effort has been directed towards inhibition of the NS3 serine protease, and potent inhibitors have now been described.  However, a clin. candidate is yet to emerge against this difficult target.  Considerable work by leading researchers has provided crystal structures of the key replicative enzymes, NS3 protease, NS3 helicase, NS5B polymerase and full-length NS3 protease-helicase, and there is much hope that such structural information will bear fruit.  More recently, inhibition of host targets, particularly inosine monophosphate dehydrogenase (IMPDH), has become of interest and there are on-going clin. trials with such inhibitors.  Research aimed at novel treatments for HCV disease is gathering pace and very recent developments in cell-based assay systems can only hasten the discovery of improved therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHjm4y0XuTNLVg90H21EOLACvtfcHk0lgxD5w_z7T5xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Srtbw%253D&md5=3f96a719833a9cf89bc565376fc7324e</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1517%2F14728214.6.1.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.6.1.13%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DEmerging%2520therapies%2520for%2520Hepatitis%2520C%2520infection%26jtitle%3DEmerging%2520Drugs%26date%3D2001%26volume%3D6%26spage%3D13%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"></span><span> </span><span class="NLM_article-title">Raffaele De Francesco and Giovanni Migliaccio</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=953-960&title=Raffaele+De+Francesco+and+Giovanni+Migliaccio"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DRaffaele%2520De%2520Francesco%2520and%2520Giovanni%2520Migliaccio%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Toniutto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirisi, M.</span><span> </span><span class="NLM_article-title">Antiviral treatment of hepatitis C</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2025</span><span class="NLM_x">–</span> <span class="NLM_lpage">2035</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1517%2F14656566.7.15.2025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=17020430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVarur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=2025-2035&author=P.+Toniuttoauthor=C.+Fabrisauthor=M.+Pirisi&title=Antiviral+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3fR"><div class="casContent"><span class="casTitleNuber">3f</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral treatment of hepatitis C</span></div><div class="casAuthors">Toniutto, Pierluigi; Fabris, Carlo; Pirisi, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2025-2035</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Therapy of hepatitis C virus (HCV) infection may prevent progression to cirrhosis, hepatocellular carcinoma and end-stage liver disease.  The cornerstone of treatment has long been std. IFN-α, the use of which was assocd. with a sustained biochem. and viral response in only a small proportion of patients.  More recently, the success of interferon-based regimens has substantially improved due to the combination with the guanosine analog ribavirin and to the advent of pegylated interferon formulations.  However, even the most up-to-date regimens fail to cure the infection in many cases and are limited by side effects and high costs.  A better understanding of the HCV genomic organization, the elucidation of the three-dimensional structures of virally encoded enzymes and the recent development of a HCV-replicon system in human hepatoma (Huh-7) cells have led to significant advances in the development of new antiviral compds., many of which are under evaluation in clin. trials.  The aim of this review is to trace a brief overview of the progress made by interferon-based treatments for hepatitis C since their introduction in the early 1990s, and to highlight the results of recent clin. studies concerning new and emerging drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_3dT3aXQ8bVg90H21EOLACvtfcHk0ljaKHEQzWxdKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVarur7K&md5=a9946b7bf2018b1c72071f197920517b</span></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=10.1517%2F14656566.7.15.2025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.7.15.2025%26sid%3Dliteratum%253Aachs%26aulast%3DToniutto%26aufirst%3DP.%26aulast%3DFabris%26aufirst%3DC.%26aulast%3DPirisi%26aufirst%3DM.%26atitle%3DAntiviral%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2006%26volume%3D7%26spage%3D2025%26epage%3D2035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kolykhalov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1128%2FJVI.74.4.2046-2051.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10644379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2046-2051&author=A.+A.+Kolykhalovauthor=K.+Mihalikauthor=S.+M.+Feinstoneauthor=C.+M.+Rice&title=Hepatitis+C+virus-encoded+enzymatic+activities+and+conserved+RNA+elements+in+the+3%E2%80%B2+nontranslated+region+are+essential+for+virus+replication+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo</span></div><div class="casAuthors">Kolykhalov, Alexander A.; Mihalik, Kathy; Feinstone, Stephen M.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2046-2051</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a widespread major human health concern.  Significant obstacles in the study of this virus include the absence of a reliable tissue culture system and a small-animal model.  Recently, full-length HCV cDNA clones were constructed and HCV infection was successfully initiated in 2 chimpanzees by intrahepatic injection of in vitro-transcribed RNA.  In order to validate potential targets for development of anti-HCV therapeutics, 6 mutant derivs. of this prototype infectious clone were constructed.  Four clones contained point mutations ablating the activity of the NS2-3 protease, the NS3-4A serine protease, the NS3 NTPase/helicase, and the NS5B polymerase.  Two addnl. clones contained deletions encompassing all or part of the highly conserved 98-base sequence at the 3' terminus of the HCV genome RNA.  The RNA transcript from each of the 6 clones was injected intrahepatically into a chimpanzee.  No signs of HCV infection were detected in the 8 mo following the injection.  Inoculation of the same animal with nonmutant RNA transcripts resulted in productive HCV infection, as evidenced by viremia, elevated serum alanine aminotransferase, and HCV-specific seroconversion.  These data suggest that these 4 HCV-encoded enzymic activities and the conserved 3' terminal RNA element are essential for productive replication in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxsUWOuM9sLVg90H21EOLACvtfcHk0ljaKHEQzWxdKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D&md5=69facc6778408ae96f31373f78c06600</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.4.2046-2051.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.4.2046-2051.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKolykhalov%26aufirst%3DA.%2BA.%26aulast%3DMihalik%26aufirst%3DK.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DHepatitis%2520C%2520virus-encoded%2520enzymatic%2520activities%2520and%2520conserved%2520RNA%2520elements%2520in%2520the%25203%25E2%2580%25B2%2520nontranslated%2520region%2520are%2520essential%2520for%2520virus%2520replication%2520in%2520vivo%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D2046%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, V.</span><span> </span><span class="NLM_article-title">Replication of hepatitis C virus</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1631</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1099%2F0022-1317-81-7-1631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10859368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks12iurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2000&pages=1631-48&author=R.+Bartenschlagerauthor=V.+Lohmann&title=Replication+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of hepatitis C virus</span></div><div class="casAuthors">Bartenschlager, Ralf; Lohmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1631-1648</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo14DohqSKFirVg90H21EOLACvtfcHk0ljaKHEQzWxdKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks12iurg%253D&md5=a7f1e41501aa786af57605084b12df28</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1099%2F0022-1317-81-7-1631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F0022-1317-81-7-1631%26sid%3Dliteratum%253Aachs%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLohmann%26aufirst%3DV.%26atitle%3DReplication%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2000%26volume%3D81%26spage%3D1631%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinküler, C.</span><span> </span><span class="NLM_article-title">Recent developments in the discovery of hepatitis C virus serine protease inhibitors—towards a new class of antiviral agents</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=153-163&author=F.+Narjesauthor=U.+Kochauthor=C.+Steink%C3%BCler&title=Recent+developments+in+the+discovery+of+hepatitis+C+virus+serine+protease+inhibitors%E2%80%94towards+a+new+class+of+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DSteink%25C3%25BCler%26aufirst%3DC.%26atitle%3DRecent%2520developments%2520in%2520the%2520discovery%2520of%2520hepatitis%2520C%2520virus%2520serine%2520protease%2520inhibitors%25E2%2580%2594towards%2520a%2520new%2520class%2520of%2520antiviral%2520agents%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D153%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maitre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.-M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Maitreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rheaumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92Activity+Study+on+a+Novel+Series+of+Macrocyclic+Inhibitors+of+the+Hepatitis+C+Virus+NS3+Protease+Leading+to+the+Discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Maitre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592Activity%2520Study%2520on%2520a%2520Novel%2520Series%2520of%2520Macrocyclic%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Leading%2520to%2520the%2520Discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schairer, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drie, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span> </span><span class="NLM_article-title">Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1939</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1939-1942&author=R.+B.+Perniauthor=L.+J.+Farmerauthor=K.+M.+Cottrellauthor=J.+J.+Courtauthor=L.+F.+Courtneyauthor=D.+D.+Deiningerauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=J.+L.+Kimauthor=C.+Linauthor=K.+Linauthor=Y.-P.+Luongauthor=J.+P.+Maxwellauthor=M.+A.+Murckoauthor=J.+Pitlikauthor=B.+G.+Raoauthor=W.+C.+Schairerauthor=R.+D.+Tungauthor=J.+H.+Van+Drieauthor=K.+Wilsonauthor=J.+A.+Thomson&title=Inhibitors+of+hepatitis+C+virus+NS3%C2%B74A+protease.+Part+3%3A+P2+proline+variants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DFarmer%26aufirst%3DL.%2BJ.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DCourt%26aufirst%3DJ.%2BJ.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DMaxwell%26aufirst%3DJ.%2BP.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DPitlik%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DSchairer%26aufirst%3DW.%2BC.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DVan%2BDrie%26aufirst%3DJ.%2BH.%26aulast%3DWilson%26aufirst%3DK.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26atitle%3DInhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%25C2%25B74A%2520protease.%2520Part%25203%253A%2520P2%2520proline%2520variants%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1939%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">Novel P4 truncated tripeptidyl α-ketoamides as HCV protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=263-266&author=J.+Lamarauthor=F.+Victorauthor=N.+Snyderauthor=R.+B.+Johnsonauthor=Q.+M.+Wangauthor=J.+I.+Glassauthor=S.-H.+Chen&title=Novel+P4+truncated+tripeptidyl+%CE%B1-ketoamides+as+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DNovel%2520P4%2520truncated%2520tripeptidyl%2520%25CE%25B1-ketoamides%2520as%2520HCV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D263%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malancona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2151</span><span class="NLM_x">–</span> <span class="NLM_lpage">2154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2151-2154&author=E.+Niziauthor=U.+Kochauthor=J.+M.+Ontoriaauthor=A.+Marchettiauthor=F.+Narjesauthor=S.+Malanconaauthor=V.+G.+Matassaauthor=C.+Gardelli&title=Capped+dipeptide+phenethylamide+inhibitors+of+the+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DCapped%2520dipeptide%2520phenethylamide%2520inhibitors%2520of%2520the%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2151%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Priestley, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavimi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span> </span><span class="NLM_article-title">P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3199</span><span class="NLM_x">–</span> <span class="NLM_lpage">3202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3199-3202&author=E.+S.+Priestleyauthor=I.+De+Luccaauthor=B.+Ghavimiauthor=S.+Erickson-Viitanenauthor=C.+P.+Decicco&title=P1+Phenethyl+peptide+boronic+acid+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26aulast%3DDe%2BLucca%26aufirst%3DI.%26aulast%3DGhavimi%26aufirst%3DB.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26atitle%3DP1%2520Phenethyl%2520peptide%2520boronic%2520acid%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3199%26epage%3D3202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as Hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5751</span><span class="NLM_x">–</span> <span class="NLM_lpage">5755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5751-5755&author=A.+Arasappanauthor=F.+G.+Njorogeauthor=T.+N.+Parekhauthor=X.+Yangauthor=J.+Pichardoauthor=N.+Butkiewiczauthor=A.+Prongayauthor=N.+Yaoauthor=V.+Girijavallabhan&title=Novel+2-oxoimidazolidine-4-carboxylic+acid+derivatives+as+Hepatitis+C+virus+NS3-4A+serine+protease+inhibitors%3A+synthesis%2C+activity%2C+and+X-ray+crystal+structure+of+an+enzyme+inhibitor+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DParekh%26aufirst%3DT.%2BN.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DNovel%25202-oxoimidazolidine-4-carboxylic%2520acid%2520derivatives%2520as%2520Hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%2520inhibitors%253A%2520synthesis%252C%2520activity%252C%2520and%2520X-ray%2520crystal%2520structure%2520of%2520an%2520enzyme%2520inhibitor%2520complex%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5751%26epage%3D5755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><div class="note"><p class="first last">For BILN-2061, see:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+BILN-2061%2C+see%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=T.+S.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lhF2aesmpCkdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DGeorge%26aufirst%3DT.%2BS.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1355-1360&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Gordreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+Inhibitors+of+the+NS3+Protease+as+Potential+Therapeutic+Agents+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGordreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520the%2520NS3%2520Protease%2520as%2520Potential%2520Therapeutic%2520Agents%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1355%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DurKin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1005-1008&author=R.+Zhangauthor=J.+P.+DurKinauthor=W.+T.+Windsor&title=Azapeptides+as+inhibitors+of+the+hepatitis+C+virus+NS3+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDurKin%26aufirst%3DJ.%2BP.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DAzapeptides%2520as%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1005%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2-P1 cyclopropyl alanine combination for improved potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4515-4519&author=S.+L.+Bogenauthor=A.+K.+Saksenaauthor=A.+Arasappanauthor=H.+Guauthor=F.+G.+Njorogeauthor=V.+Girijavallabhanauthor=J.+Pichardoauthor=N.+Butkiewiczauthor=A.+Prongayauthor=V.+Madison&title=Hepatitis+C+virus+NS3-4A+serine+protease+inhibitors%3A+use+of+a+P2-P1+cyclopropyl+alanine+combination+for+improved+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DHepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%2520inhibitors%253A%2520use%2520of%2520a%2520P2-P1%2520cyclopropyl%2520alanine%2520combination%2520for%2520improved%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4515%26epage%3D4519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span> </span><span class="NLM_article-title">α-Ketoamides, α-ketoesters and α-diketones as HCV NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=711-713&author=W.+Hanauthor=Z.+Huauthor=X.+Jiangauthor=C.+P.+Decicco&title=%CE%B1-Ketoamides%2C+%CE%B1-ketoesters+and+%CE%B1-diketones+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26atitle%3D%25CE%25B1-Ketoamides%252C%2520%25CE%25B1-ketoesters%2520and%2520%25CE%25B1-diketones%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D711%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumibe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=257-261&author=F.+Victorauthor=J.+Lamarauthor=N.+Snyderauthor=Y.+Yipauthor=D.+Guoauthor=N.+Yumibeauthor=R.+B.+Johnsonauthor=Q.+M.+Wangauthor=J.+I.+Glassauthor=S.-H.+Chen&title=P1+and+P3+optimization+of+novel+bicycloproline+P2+bearing+tetrapeptidyl+%CE%B1-ketoamide+based+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DN.%26aulast%3DYip%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYumibe%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DP1%2520and%2520P3%2520optimization%2520of%2520novel%2520bicycloproline%2520P2%2520bearing%2520tetrapeptidyl%2520%25CE%25B1-ketoamide%2520based%2520HCV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D257%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><div class="note"><p class="first last">For SCH 503034, see:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+SCH+503034%2C+see%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J. J.</span><span> </span><span class="NLM_article-title">Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=50-59&author=F.+G.+Njorogeauthor=K.+X.+Chenauthor=N.-Y.+Shihauthor=J.+J.+Piwinski&title=Challenges+in+Modern+Drug+Discovery%3A+A+Case+Study+of+Boceprevir%2C+an+HCV+Protease+Inhibitor+for+the+Treatment+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Far700109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700109k%26sid%3Dliteratum%253Aachs%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26atitle%3DChallenges%2520in%2520Modern%2520Drug%2520Discovery%253A%2520A%2520Case%2520Study%2520of%2520Boceprevir%252C%2520an%2520HCV%2520Protease%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D50%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)-amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable, hepatitis C virus NS3 protease inhibitor: A potential therapeutic agent for the treatment of hepatitis C infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=T.+Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2-3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29-amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexane-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable%2C+hepatitis+C+virus+NS3+protease+inhibitor%3A+A+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2-3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529-amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexane-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%252C%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520A%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.+P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.%2BP.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khunvichai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span> </span><span class="NLM_article-title">Antiviral effects and safety of telaprevir peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1016%2Fj.jhep.2008.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=18486984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlWqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=163-169&author=E.+Lawitzauthor=M.+Rodriguez-Torresauthor=A.+J.+Muirauthor=T.+L.+Kiefferauthor=L.+McNairauthor=A.+Khunvichaiauthor=J.+G.+McHutchison&title=Antiviral+effects+and+safety+of+telaprevir+peginterferon+alfa-2a%2C+and+ribavirin+for+28+days+in+hepatitis+C+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients</span></div><div class="casAuthors">Lawitz, Eric; Rodriguez-Torres, Maribel; Muir, Andrew J.; Kieffer, Tara L.; McNair, Lindsay; Khunvichai, Ariya; McHutchison, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-169</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study assessed the safety and antiviral effects of telaprevir (VX-950) in combination with peginterferon alfa-2a and ribavirin.  Twelve treatment-naive patients with chronic genotype 1 hepatitis C virus infection received telaprevir (750 mg q8h), peginterferon alfa-2a (180 μg/wk), and ribavirin (1000 or 1200 mg/day) for 28 days.  Patients could then start off-study treatment with peginterferon alfa-2a and ribavirin for up to 44 wk, at the discretion of the investigator and patient.  The combination of telaprevir, peginterferon alfa-2a, and ribavirin was well tolerated, with no serious adverse events or treatment discontinuations.  Rash or pruritus occurred in 5 of the 12 patients; all cases resolved either during or after the end of telaprevir treatment.  All 12 patients had undetectable HCV RNA levels by day 28 (rapid viral response, RVR).  Eight patients completed 44 wk of off-study peginterferon alfa-2a and ribavirin treatment.  Eight patients achieved a sustained viral response (SVR), including one patient who received only 22 wk of treatment.  The combination of telaprevir, peginterferon alfa-2a, and ribavirin was generally well tolerated.  Events of pruritus and rash resolved during or after end of telaprevir dosing.  All 12 patients achieved an RVR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaZPUDf_0tJLVg90H21EOLACvtfcHk0lie8BUF7skRdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlWqsbo%253D&md5=2a5f653f8cfe56c4501907397886aad6</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2008.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2008.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DMuir%26aufirst%3DA.%2BJ.%26aulast%3DKieffer%26aufirst%3DT.%2BL.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DKhunvichai%26aufirst%3DA.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26atitle%3DAntiviral%2520effects%2520and%2520safety%2520of%2520telaprevir%2520peginterferon%2520alfa-2a%252C%2520and%2520ribavirin%2520for%252028%2520days%2520in%2520hepatitis%2520C%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2008%26volume%3D49%26spage%3D163%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mederacke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M.</span><span> </span><span class="NLM_article-title">P Boceprevir an NS3 serine protease inhibitor of hepatitis C virus for the treatment of HCV infection</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=19197796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1Kitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=181-9&author=I.+Mederackeauthor=H.+Wedemeyerauthor=M.+Manns&title=P+Boceprevir+an+NS3+serine+protease+inhibitor+of+hepatitis+C+virus+for+the+treatment+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection</span></div><div class="casAuthors">Mederacke, Ingmar; Wedemeyer, Heiner; Manns, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (BioMed Central)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-189</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">2040-3429</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Boceprevir is an HCV NS3 (non-structural protein 3) serine protease inhibitor being developed by Schering-Plough Corp as a capsule formulation.  In pharmacokinetic studies, boceprevir was adequately absorbed, with the most effective mode of administration appearing to be a three-times-daily regimen.  In phase I clin. trials, monotherapy with baceprevir led to a distinct viral load redn.  In phase 1b combination trials of baceprevir with PEGylated IFNα2b and ribavirin, the redn. in viral replication was further increased.  Early data reported from phase II clin. trials have been promising, suggesting a rapid early HCV-RNA redn.  Phase III trials for the drug began in 2008.  Results available to date have demonstrated the compd. to be well tolerated, with adverse events that were within the range of current std.-of-care therapy.  Thus, boceprevir may have the potential to increase sustained virol. response rates and possibly also to shorten duration of therapy; data from ongoing clin. trials are awaited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLYKUOStRMTbVg90H21EOLACvtfcHk0lie8BUF7skRdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1Kitb8%253D&md5=bbe724393fa436b8740b5d8fde25b1c9</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMederacke%26aufirst%3DI.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DManns%26aufirst%3DM.%26atitle%3DP%2520Boceprevir%2520an%2520NS3%2520serine%2520protease%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520for%2520the%2520treatment%2520of%2520HCV%2520infection%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D181%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, Michael, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Bang-Lin; Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=T.+B.+Rudd%2C+Michaelauthor=W.+Johnauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=D.+B.+Wan%2C+Bang-Lin%3B+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%252C%2BMichael%26aufirst%3DT.%2BB.%26aulast%3DJohn%26aufirst%3DW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%252C%2BBang-Lin%253B%2BOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zeuzem, S.; Sarrazin, C.; Rouzier, R.; Tarral, A.; Brion, N.; Forestier, N.; Gupta, S.; Deckman, D.; Fellows, K.; Hussain, M.; Cutler, D.; Zhang, J.</span> In <span class="NLM_conf-name">56th Annual Meeting of AASLD</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zeuzem%2C+S.%3B+Sarrazin%2C+C.%3B+Rouzier%2C+R.%3B+Tarral%2C+A.%3B+Brion%2C+N.%3B+Forestier%2C+N.%3B+Gupta%2C+S.%3B+Deckman%2C+D.%3B+Fellows%2C+K.%3B+Hussain%2C+M.%3B+Cutler%2C+D.%3B+Zhang%2C+J.+In+56th+Annual+Meeting+of+AASLD%2C+San+Francisco%2C+CA%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZeuzem%26aufirst%3DS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For combination therapy with pegylated interferon α-2b see</p></div> : <span class="NLM_contrib-group">Sarrazin, C.; Rouzier, R.; Wagner, F.; Forestier, N.; Larrey, D.; Gupta, S. K.; Hussain, M.; Shah, A.; Cutler, D.; Zhang, J.; Zeuzem, S.</span><span> </span><span class="NLM_article-title">SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders</span>.  <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span>− <span class="NLM_lpage">1278</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=1270-1278&author=C.+Sarrazin&author=R.+Rouzier&author=F.+Wagner&author=N.+Forestier&author=D.+Larrey&author=S.+K.+Gupta&author=M.+Hussain&author=A.+Shah&author=D.+Cutler&author=J.+Zhang&author=S.+Zeuzem&title=SCH+503034%2C+a+Novel+Hepatitis+C+Virus+Protease+Inhibitor%2C+Plus+Pegylated+Interferon+%CE%B1-2b+for+Genotype+1+Nonresponders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarrazin%26aufirst%3DC.%26atitle%3DSCH%2520503034%252C%2520a%2520Novel%2520Hepatitis%2520C%2520Virus%2520Protease%2520Inhibitor%252C%2520Plus%2520Pegylated%2520Interferon%2520%25CE%25B1-2b%2520for%2520Genotype%25201%2520Nonresponders%26jtitle%3DGastroenterology%26date%3D2007%26volume%3D132%26spage%3D1270%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pfitzner, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffatt, J. G.</span><span> </span><span class="NLM_article-title">A new and selective oxidation of alcohols</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3027</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00902a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADyaF3sXkvVantbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1963&pages=3027&author=K.+E.+Pfitznerauthor=J.+G.+Moffatt&title=A+new+and+selective+oxidation+of+alcohols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of nucleoside 5'-carboxaldehydes</span></div><div class="casAuthors">Pfitzner, K. E.; Moffatt, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3027</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Addn. of dicyclohexylcarbodiimide (I) to an anhyd. soln. of pyridinium thymidine 5'-phosphate in Me2SO after 1 hr. at room temp. gave thymine (II) and inorg. phosphates.  A similar release of II resulted from P1,P2-dithymidine pyrophosphate, thymidine, and 5'-O-acetylthymidine, but not from 3'-O-acetylthymidine 5'phosphate, 3'-deoxythymidine 5'-phosphate, or the corresponding nucleosides in the presence of phosphate.  Treatment of 1 millimole 3'-O-acetylthymidine in 3 ml. anhyd. Me2SO contg. 0.5 millimole phosphoric acid with 3-5 millimoles I for several hrs. at room temp. gave no release of II, but rather 3'-O-acetyl thymidine 5'-carboxaldehyde (III), λ 267 mμ in H2O [2,4-di-nitrophenylhydrazone m. 233-34°,  (MeOH) 261 and 350 mμ (ε 19,300 and 21,650)], completely free of acidic nucleoside derivs. Redn. of III with NaBH4 gave II, while oxidn. of III with NaOI gave 3'-O-acetylthymidine 5'-carboxylic acid, which on alk. hydrolysis gave thymidine 5'-carboxylic acid. Similarly, the reaction of 2',3'-O-isopropylideneuridine and 2',3'-O-iso-propylideneadenosine with I and 0.5 mole-equiv. pyridinium trifluoroacetate or pyridinium phosphate in anhyd.  Me2SO, followed by treatment with 10% HOAc at 100° for 1 hr., gave uridine 5'carboxaldehyde and adenosine 5'-carboxaldehyde.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-8EJfx87wgbVg90H21EOLACvtfcHk0lhrLs3oA9AMyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXkvVantbY%253D&md5=3f46daf90e60de38496a7379b113674e</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fja00902a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00902a036%26sid%3Dliteratum%253Aachs%26aulast%3DPfitzner%26aufirst%3DK.%2BE.%26aulast%3DMoffatt%26aufirst%3DJ.%2BG.%26atitle%3DA%2520new%2520and%2520selective%2520oxidation%2520of%2520alcohols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1963%26volume%3D85%26spage%3D3027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dess, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">A Useful 12-I-5 Triacetoxyperiodinane (the Dess−Martin Periodinane) for the Selective Oxidation of Primary or Secondary Alcohols and a Variety of Related 12-I-5 Species</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">7277</span><span class="NLM_x">–</span> <span class="NLM_lpage">7287</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00019a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=7277-7287&author=D.+B.+Dessauthor=J.+C.+Martin&title=A+Useful+12-I-5+Triacetoxyperiodinane+%28the+Dess%E2%88%92Martin+Periodinane%29+for+the+Selective+Oxidation+of+Primary+or+Secondary+Alcohols+and+a+Variety+of+Related+12-I-5+Species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fja00019a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00019a027%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DA%2520Useful%252012-I-5%2520Triacetoxyperiodinane%2520%2528the%2520Dess%25E2%2588%2592Martin%2520Periodinane%2529%2520for%2520the%2520Selective%2520Oxidation%2520of%2520Primary%2520or%2520Secondary%2520Alcohols%2520and%2520a%2520Variety%2520of%2520Related%252012-I-5%2520Species%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D7277%26epage%3D7287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Peterson, D. J.</span><span> </span><span class="NLM_article-title">Carbonyl olefination reaction using silyl-substituted organometallic compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1968&pages=780-784&author=D.+J.+Peterson&title=Carbonyl+olefination+reaction+using+silyl-substituted+organometallic+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DD.%2BJ.%26atitle%3DCarbonyl%2520olefination%2520reaction%2520using%2520silyl-substituted%2520organometallic%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1968%26volume%3D34%26spage%3D780%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B. A.</span><span> </span><span class="NLM_article-title">A Continuous Spectrophotometric Assay for the Hepatitis C Virus Serine Protease</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><div class="note"><p class="first last">The substrate Ac-DTEDVVP(Nva)-O-PAP was used in the present study</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1999&pages=268-275&author=R.+Zhangauthor=B.+M.+Beyerauthor=J.+Durkinauthor=R.+Ingramauthor=F.+G.+Njorogeauthor=W.+T.+Windsorauthor=B.+A.+Malcolm&title=A+Continuous+Spectrophotometric+Assay+for+the+Hepatitis+C+Virus+Serine+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26atitle%3DA%2520Continuous%2520Spectrophotometric%2520Assay%2520for%2520the%2520Hepatitis%2520C%2520Virus%2520Serine%2520Protease%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D270%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+Kornerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0lhrLs3oA9AMyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uss, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span> </span><span class="NLM_article-title">Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1186</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=1186-1197&author=C.+Liauthor=L.+Nairauthor=T.+Liuauthor=F.+Liauthor=J.+Pichardoauthor=S.+Agrawalauthor=R.+Chaseauthor=X.+Tongauthor=A.+S.+Ussauthor=S.+Bogenauthor=F.+G.+Njorogeauthor=R.+A.+Morissonauthor=K.-C.+Cheng&title=Correlation+between+PAMPA+permeability+and+cellular+activities+of+hepatitis+C+virus+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DNair%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DUss%26aufirst%3DA.%2BS.%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMorisson%26aufirst%3DR.%2BA.%26aulast%3DCheng%26aufirst%3DK.-C.%26atitle%3DCorrelation%2520between%2520PAMPA%2520permeability%2520and%2520cellular%2520activities%2520of%2520hepatitis%2520C%2520virus%2520protease%2520inhibitors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D1186%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e','cit3f'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g'],'ref6':['cit6','cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b'],'ref9':['cit9','cit9a','cit9b'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ittipat Meewan, Xingquan Zhang, Suchismita Roy, Carlo Ballatore, Anthony J. O’Donoghue, Robert T. Schooley, <span class="NLM_string-name hlFld-ContribAuthor">Ruben Abagyan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (16)
                                     , 16999-17008. <a href="https://doi.org/10.1021/acsomega.9b02491" title="DOI URL">https://doi.org/10.1021/acsomega.9b02491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b02491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b02491%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDiscovery%252Bof%252BNew%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252Band%252BIts%252BD168A%252BMutant%26aulast%3DMeewan%26aufirst%3DIttipat%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06082019%26date%3D02092019%26date%3D02102019%26volume%3D4%26issue%3D16%26spage%3D16999%26epage%3D17008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dinesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Sandeep R.  Vemula</span>, and <span class="hlFld-ContribAuthor ">Gregory R.  Cook</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Catalytic Synthesis of α-Ketoamides. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2016,</strong> <em>6 </em>
                                    (8)
                                     , 4920-4945. <a href="https://doi.org/10.1021/acscatal.6b01116" title="DOI URL">https://doi.org/10.1021/acscatal.6b01116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.6b01116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.6b01116%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BCatalytic%252BSynthesis%252Bof%252B%2525CE%2525B1-Ketoamides%26aulast%3DKumar%26aufirst%3DDinesh%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19042016%26date%3D14062016%26date%3D28062016%26date%3D05082016%26date%3D17062016%26volume%3D6%26issue%3D8%26spage%3D4920%26epage%3D4945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dinesh S.  Bhalerao</span>, <span class="hlFld-ContribAuthor ">Anil Kumar Reddy  Arkala</span>, <span class="hlFld-ContribAuthor ">Y. V.  Madhavi</span>, <span class="hlFld-ContribAuthor ">M.  Nagaraju</span>, <span class="hlFld-ContribAuthor ">Srinivas Reddy  Gade</span>, <span class="hlFld-ContribAuthor ">U. K. Syam  Kumar</span>, <span class="hlFld-ContribAuthor ">Rakeshwar  Bandichhor</span>, and <span class="hlFld-ContribAuthor ">Vilas H.  Dahanukar</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Process Optimization of Boceprevir: A Protease Inhibitor Drug. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (11)
                                     , 1559-1567. <a href="https://doi.org/10.1021/op500065t" title="DOI URL">https://doi.org/10.1021/op500065t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op500065t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop500065t%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Band%252BProcess%252BOptimization%252Bof%252BBoceprevir%25253A%252BA%252BProtease%252BInhibitor%252BDrug%26aulast%3DBhalerao%26aufirst%3DDinesh%2BS.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D22022014%26date%3D08082014%26date%3D20112015%26date%3D21072014%26volume%3D19%26issue%3D11%26spage%3D1559%26epage%3D1567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashok  Arasappan</span>, <span class="hlFld-ContribAuthor ">Frank  Bennett</span>, <span class="hlFld-ContribAuthor ">Stephane L.  Bogen</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Melissa  Blackman</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Siska  Hendrata</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Regina M.  Huelgas</span>, <span class="hlFld-ContribAuthor ">Latha  Nair</span>, <span class="hlFld-ContribAuthor ">Angela I.  Padilla</span>, <span class="hlFld-ContribAuthor ">Weidong  Pan</span>, <span class="hlFld-ContribAuthor ">Russell  Pike</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Sumei  Ruan</span>, <span class="hlFld-ContribAuthor ">Mousumi  Sannigrahi</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Wanli  Wu</span>, <span class="hlFld-ContribAuthor ">Weiying  Yang</span>, <span class="hlFld-ContribAuthor ">Anil K.  Saksena</span>, <span class="hlFld-ContribAuthor ">Viyyoor  Girijavallabhan</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">Jianshe  Kong</span>, <span class="hlFld-ContribAuthor ">Tao  Meng</span>, <span class="hlFld-ContribAuthor ">Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Jesse  Wong</span>, <span class="hlFld-ContribAuthor ">Paul  McNamara</span>, <span class="hlFld-ContribAuthor ">Andrew  Prongay</span>, <span class="hlFld-ContribAuthor ">Vincent  Madison</span>, <span class="hlFld-ContribAuthor ">John J.  Piwinski</span>, <span class="hlFld-ContribAuthor ">Kuo-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Richard  Morrison</span>, <span class="hlFld-ContribAuthor ">Bruce  Malcolm</span>, <span class="hlFld-ContribAuthor ">Xiao  Tong</span>, <span class="hlFld-ContribAuthor ">Robert  Ralston</span> and <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>1 </em>
                                    (2)
                                     , 64-69. <a href="https://doi.org/10.1021/ml9000276" title="DOI URL">https://doi.org/10.1021/ml9000276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml9000276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml9000276%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BNarlaprevir%252B%252528SCH%252B900518%252529%25253A%252BA%252BPotent%25252C%252BSecond%252BGeneration%252BHCV%252BNS3%252BSerine%252BProtease%252BInhibitor%26aulast%3DArasappan%26aufirst%3DAshok%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D22122009%26date%3D24012010%26date%3D15022010%26date%3D13052010%26volume%3D1%26issue%3D2%26spage%3D64%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francisco  Velázquez</span>, <span class="hlFld-ContribAuthor ">Mousumi  Sannigrahi</span>, <span class="hlFld-ContribAuthor ">Frank  Bennett</span>, <span class="hlFld-ContribAuthor ">Raymond G.  Lovey</span>, <span class="hlFld-ContribAuthor ">Ashok  Arasappan</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bogen</span>, <span class="hlFld-ContribAuthor ">Latha  Nair</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Melissa  Blackman</span>, <span class="hlFld-ContribAuthor ">Siska  Hendrata</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Regina  Huelgas</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Kuo-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiao  Tong</span>, <span class="hlFld-ContribAuthor ">Andrew T.  McPhail</span> and <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic Sulfones as Novel P3-Caps for Hepatitis C Virus NS3/4A (HCV NS3/4A) Protease Inhibitors: Synthesis and Evaluation of Inhibitors with Improved Potency and Pharmacokinetic Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (8)
                                     , 3075-3085. <a href="https://doi.org/10.1021/jm9016027" title="DOI URL">https://doi.org/10.1021/jm9016027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9016027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9016027%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclic%252BSulfones%252Bas%252BNovel%252BP3-Caps%252Bfor%252BHepatitis%252BC%252BVirus%252BNS3%25252F4A%252B%252528HCV%252BNS3%25252F4A%252529%252BProtease%252BInhibitors%25253A%252BSynthesis%252Band%252BEvaluation%252Bof%252BInhibitors%252Bwith%252BImproved%252BPotency%252Band%252BPharmacokinetic%252BProfiles%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DFrancisco%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D29102009%26date%3D19032010%26date%3D22042010%26volume%3D53%26issue%3D8%26spage%3D3075%26epage%3D3085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dita  Spálovská</span>, <span class="hlFld-ContribAuthor ">Martin  Paškan</span>, <span class="hlFld-ContribAuthor ">Bronislav  Jurásek</span>, <span class="hlFld-ContribAuthor ">Martin  Kuchař</span>, <span class="hlFld-ContribAuthor ">Michal  Kohout</span>, <span class="hlFld-ContribAuthor ">Vladimír  Setnička</span>. </span><span class="cited-content_cbyCitation_article-title">Structural spectroscopic study of enantiomerically pure synthetic cathinones and their major metabolites. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (2)
                                     , 850-860. <a href="https://doi.org/10.1039/D0NJ05065B" title="DOI URL">https://doi.org/10.1039/D0NJ05065B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ05065B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ05065B%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DStructural%252Bspectroscopic%252Bstudy%252Bof%252Benantiomerically%252Bpure%252Bsynthetic%252Bcathinones%252Band%252Btheir%252Bmajor%252Bmetabolites%26aulast%3DSp%25C3%25A1lovsk%25C3%25A1%26aufirst%3DDita%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D2%26spage%3D850%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debarati  Das</span>, <span class="hlFld-ContribAuthor ">Bhalchandra M.  Bhanage</span>. </span><span class="cited-content_cbyCitation_article-title">Double Carbonylation Reactions: Overview and Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (15)
                                     , 3022-3058. <a href="https://doi.org/10.1002/adsc.202000245" title="DOI URL">https://doi.org/10.1002/adsc.202000245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000245%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DDouble%252BCarbonylation%252BReactions%25253A%252BOverview%252Band%252BRecent%252BAdvances%26aulast%3DDas%26aufirst%3DDebarati%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D15%26spage%3D3022%26epage%3D3058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of HCV NS3/4a Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 231-259. <a href="https://doi.org/10.1007/7355_2018_39" title="DOI URL">https://doi.org/10.1007/7355_2018_39</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_39%26sid%3Dliteratum%253Aachs%26atitle%3DEvolution%252Bof%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitors%26aulast%3DLiverton%26aufirst%3DNigel%2BJ.%26date%3D2019%26date%3D2019%26spage%3D231%26epage%3D259%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narasimha Swamy  Thirukovela</span>, <span class="hlFld-ContribAuthor ">Ramesh  Balaboina</span>, <span class="hlFld-ContribAuthor ">Ravinder  Vadde</span>, <span class="hlFld-ContribAuthor ">Chandra  Sekhar Vasam</span>. </span><span class="cited-content_cbyCitation_article-title">Water dispersed gold nanoparticles catalyzed aerobic oxidative cross-dehydrogenative coupling: An efficient synthesis of α-ketoamides in water. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (42)
                                     , 3749-3752. <a href="https://doi.org/10.1016/j.tetlet.2018.08.042" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.08.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.08.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.08.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DWater%252Bdispersed%252Bgold%252Bnanoparticles%252Bcatalyzed%252Baerobic%252Boxidative%252Bcross-dehydrogenative%252Bcoupling%25253A%252BAn%252Befficient%252Bsynthesis%252Bof%252B%2525CE%2525B1-ketoamides%252Bin%252Bwater%26aulast%3DThirukovela%26aufirst%3DNarasimha%2BSwamy%26date%3D2018%26volume%3D59%26issue%3D42%26spage%3D3749%26epage%3D3752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Amy  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Min  Lee</span>, <span class="hlFld-ContribAuthor ">Cindy  Dunaj</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Jay  Knipe</span>, <span class="hlFld-ContribAuthor ">Jason  Sandquist</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dawn  Parker</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1853-1859. <a href="https://doi.org/10.1016/j.bmcl.2018.04.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DP3-P4%252Bureas%252Band%252Breverse%252Bcarbamates%252Bas%252Bpotent%252BHCV%252BNS3%252Bprotease%252Binhibitors%25253A%252BEffective%252Btransposition%252Bof%252Bthe%252BP4%252Bhydrogen%252Bbond%252Bdonor%26aulast%3DVenables%26aufirst%3DBrian%2BL.%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1853%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsuo  Kanda</span>, <span class="hlFld-ContribAuthor ">Osamu  Yokosuka</span>, <span class="hlFld-ContribAuthor ">Masao  Omata</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of hepatitis C virus infection in the future. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Medicine</span><span> <strong>2013,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/2001-1326-2-9" title="DOI URL">https://doi.org/10.1186/2001-1326-2-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/2001-1326-2-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F2001-1326-2-9%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Medicine%26atitle%3DTreatment%252Bof%252Bhepatitis%252BC%252Bvirus%252Binfection%252Bin%252Bthe%252Bfuture%26aulast%3DKanda%26aufirst%3DTatsuo%26date%3D2013%26date%3D2013%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martijn  Risseeuw</span>, <span class="hlFld-ContribAuthor ">Mark  Overhand</span>, <span class="hlFld-ContribAuthor ">George W. J.  Fleet</span>, <span class="hlFld-ContribAuthor ">Michela I.  Simone</span>. </span><span class="cited-content_cbyCitation_article-title">A compendium of cyclic sugar amino acids and their carbocyclic and heterocyclic nitrogen analogues. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2013,</strong> <em>45 </em>
                                    (4)
                                     , 613-689. <a href="https://doi.org/10.1007/s00726-013-1521-1" title="DOI URL">https://doi.org/10.1007/s00726-013-1521-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-013-1521-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-013-1521-1%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DA%252Bcompendium%252Bof%252Bcyclic%252Bsugar%252Bamino%252Bacids%252Band%252Btheir%252Bcarbocyclic%252Band%252Bheterocyclic%252Bnitrogen%252Banalogues%26aulast%3DRisseeuw%26aufirst%3DMartijn%26date%3D2013%26date%3D2013%26volume%3D45%26issue%3D4%26spage%3D613%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. V.  Yashin</span>, <span class="hlFld-ContribAuthor ">E. B.  Averina</span>, <span class="hlFld-ContribAuthor ">K. N.  Sedenkova</span>, <span class="hlFld-ContribAuthor ">T. S.  Kuznetsova</span>, <span class="hlFld-ContribAuthor ">N. S.  Zefirov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino acids of cyclopropylglycine series. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2013,</strong> <em>62 </em>
                                    (4)
                                     , 928-952. <a href="https://doi.org/10.1007/s11172-013-0123-0" title="DOI URL">https://doi.org/10.1007/s11172-013-0123-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-013-0123-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-013-0123-0%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DSynthesis%252Bof%252Bamino%252Bacids%252Bof%252Bcyclopropylglycine%252Bseries%26aulast%3DYashin%26aufirst%3DN.%2BV.%26date%3D2013%26date%3D2014%26volume%3D62%26issue%3D4%26spage%3D928%26epage%3D952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Boceprevir and Narlaprevir: The First and Second Generation of HCV NS3 Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 296-335. <a href="https://doi.org/10.1002/9781118219683.ch12" title="DOI URL">https://doi.org/10.1002/9781118219683.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118219683.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118219683.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BBoceprevir%252Band%252BNarlaprevir%25253A%252BThe%252BFirst%252Band%252BSecond%252BGeneration%252Bof%252BHCV%252BNS3%252BProtease%252BInhibitors%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2012%26date%3D2012%26spage%3D296%26epage%3D335%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DCase%252BStudies%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DHuang%26aufirst%3DXianhai%26date%3D2012%26volume%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Steuer</span>, <span class="hlFld-ContribAuthor ">Christian  Gege</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Fischl</span>, <span class="hlFld-ContribAuthor ">Karl H.  Heinonen</span>, <span class="hlFld-ContribAuthor ">Ralf  Bartenschlager</span>, <span class="hlFld-ContribAuthor ">Christian D.  Klein</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (13)
                                     , 4067-4074. <a href="https://doi.org/10.1016/j.bmc.2011.05.015" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.05.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.05.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B%2525CE%2525B1-ketoamides%252Bas%252Binhibitors%252Bof%252Bthe%252BDengue%252Bvirus%252Bprotease%252Bwith%252Bantiviral%252Bactivity%252Bin%252Bcell-culture%26aulast%3DSteuer%26aufirst%3DChristian%26date%3D2011%26volume%3D19%26issue%3D13%26spage%3D4067%26epage%3D4074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Liu</span>, <span class="hlFld-ContribAuthor ">Han  Zhou</span>, <span class="hlFld-ContribAuthor ">Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Xi  Chen</span>, <span class="hlFld-ContribAuthor ">Ruixin  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study. </span><span class="cited-content_cbyCitation_journal-name">BMC Bioinformatics</span><span> <strong>2011,</strong> <em>12 </em>
                                    (1)
                                     , 294. <a href="https://doi.org/10.1186/1471-2105-12-294" title="DOI URL">https://doi.org/10.1186/1471-2105-12-294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1471-2105-12-294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1471-2105-12-294%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Bioinformatics%26atitle%3DMulti-target%252BQSAR%252Bmodelling%252Bin%252Bthe%252Banalysis%252Band%252Bdesign%252Bof%252BHIV-HCV%252Bco-inhibitors%25253A%252Ban%252Bin-silico%252Bstudy%26aulast%3DLiu%26aufirst%3DQi%26date%3D2011%26volume%3D12%26issue%3D1%26spage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasuhiko  Sugawara</span>, <span class="hlFld-ContribAuthor ">Sumihito  Tamura</span>, <span class="hlFld-ContribAuthor ">Norihiro  Kokudo</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation. </span><span class="cited-content_cbyCitation_journal-name">Hepatitis Research and Treatment</span><span> <strong>2010,</strong> <em>2010 </em>, 1-9. <a href="https://doi.org/10.1155/2010/475746" title="DOI URL">https://doi.org/10.1155/2010/475746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2010/475746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2010%2F475746%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatitis%2520Research%2520and%2520Treatment%26atitle%3DAntiviral%252BTreatment%252Bfor%252BHepatitis%252BC%252BVirus%252BInfection%252Bafter%252BLiver%252BTransplantation%26aulast%3DSugawara%26aufirst%3DYasuhiko%26date%3D2010%26volume%3D2010%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hans L.  Tillmann</span>, <span class="hlFld-ContribAuthor ">John G.  McHutchison</span>. </span><span class="cited-content_cbyCitation_article-title">Use of Thrombopoietic Agents for the Thrombocytopenia of Liver Disease. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Hematology</span><span> <strong>2010,</strong> <em>47 </em>
                                    (3)
                                     , 266-273. <a href="https://doi.org/10.1053/j.seminhematol.2010.04.003" title="DOI URL">https://doi.org/10.1053/j.seminhematol.2010.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.seminhematol.2010.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.seminhematol.2010.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Hematology%26atitle%3DUse%252Bof%252BThrombopoietic%252BAgents%252Bfor%252Bthe%252BThrombocytopenia%252Bof%252BLiver%252BDisease%26aulast%3DTillmann%26aufirst%3DHans%2BL.%26date%3D2010%26volume%3D47%26issue%3D3%26spage%3D266%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stéphane L.  Bogen</span>, <span class="hlFld-ContribAuthor ">Ashok  Arasappan</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Melissa  Blackman</span>, <span class="hlFld-ContribAuthor ">Regina  Huelgas</span>, <span class="hlFld-ContribAuthor ">Weidong  Pan</span>, <span class="hlFld-ContribAuthor ">Elise  Siegel</span>, <span class="hlFld-ContribAuthor ">Latha G.  Nair</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Zhuyan  Guo</span>, <span class="hlFld-ContribAuthor ">Ronald  Doll</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">F.  George Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical species. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2010,</strong> <em>18 </em>
                                    (5)
                                     , 1854-1865. <a href="https://doi.org/10.1016/j.bmc.2010.01.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.01.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.01.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.01.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Bsulfonamide%252BP4-capped%252Bketoamide%252Bsecond%252Bgeneration%252Binhibitors%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS3%252Bserine%252Bprotease%252Bwith%252Bfavorable%252Bpharmacokinetic%252Bprofiles%252Bin%252Bpreclinical%252Bspecies%26aulast%3DBogen%26aufirst%3DSt%25C3%25A9phane%2BL.%26date%3D2010%26volume%3D18%26issue%3D5%26spage%3D1854%26epage%3D1865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Latha G.  Nair</span>, <span class="hlFld-ContribAuthor ">Mousumi  Sannigrahi</span>, <span class="hlFld-ContribAuthor ">Stephane  Bogen</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Andrew  Prongay</span>, <span class="hlFld-ContribAuthor ">Xiao  Tong</span>, <span class="hlFld-ContribAuthor ">K.-C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Viyyoor  Girijavallabhan</span>, <span class="hlFld-ContribAuthor ">F.  George Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profile. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (2)
                                     , 567-570. <a href="https://doi.org/10.1016/j.bmcl.2009.11.094" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.094%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DP4%252Bcapped%252Bamides%252Band%252Blactams%252Bas%252BHCV%252BNS3%252Bprotease%252Binhibitors%252Bwith%252Bimproved%252Bpotency%252Band%252BDMPK%252Bprofile%26aulast%3DNair%26aufirst%3DLatha%2BG.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D567%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Profile of <b>1</b> (SCH 503034).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Profile of <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0013.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) (i) Boc-<i>t</i>-leucine, EDC, HOOBt; DMF/CH<sub>2</sub>Cl<sub>2</sub>, iPr<sub>2</sub>NEt, 0 °C; (ii) LiOH, THF·MeOH/H<sub>2</sub>O, 0 °C; (b) (i) HATU, DMF, DIPEA, −20 °C; (ii) Cl<sub>2</sub>CO<sub>2</sub>H, EDCI·HCl, DMSO, 0 °C (R′ = H); Dess−Martin periodinane, RT (R′ = alkyls); (iii) 4 M HCl; <i>p</i>-dioxane, RT; (c) CH<sub>2</sub>Cl<sub>2</sub>, iPr<sub>2</sub>NEt, 0 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0014.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) EDCI, 4-DMAP, ROH, 0 °C; (b) HATU, DMF, DIPEA, R’NH<sub>2</sub>, −20 °C. (c) (i) EDCI, NMM, HCl·HN(OMe)Me, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (ii) R′′MgBr or R′′MgCl or R′′Li, Et<sub>2</sub>O or THF, −78 °C. (d) (i) 4 M HCl <i>p</i>-dioxane, RT; (ii) phosgene, NaHCO<sub>3</sub>, H<sub>2</sub>O /CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0001.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) (i) TMSCH<sub>2</sub>MgCl, THF, 0 °C; (ii) KHMDS, THF, 0 °C; (iii) 4 M HCl <i>p</i>-dioxane, RT. (b) (i) NaBH<sub>4</sub>, MeOH, 0 °C (R = OH); (ii) H<sub>2</sub>, MeOH, 10%Pd/C, RT (R = H); (iii) 4 M HCl <i>p</i>-dioxane, RT. (c) (i) MeONH<sub>2</sub>.HCl, pyridine, 50 °C; (ii) 50% TFA in CH<sub>2</sub>Cl<sub>2</sub>, RT. (d) Phosgene, NaHCO<sub>3</sub>, H<sub>2</sub>O /CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/medium/jm-2008-01632a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0010.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of compound <b>68</b> bound to the active site of HCV NS3/NS4A protease domain. The inhibitor is shown as stick and the protein as surface. The S1−S4 subsites and the residues that occupy the S4 pocket are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-12/jm801632a/production/images/large/jm-2008-01632a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801632a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 17 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span>World Health Organization Fact Sheet Number 164; <span class="NLM_month">October</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization+Fact+Sheet+Number+164%3B+October%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Health%2520Organization%2520Fact%2520Sheet%2520Number%2520164%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wasley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Epidemiology of hepatitis C: geographic differences and temporal trends</span> <span class="citation_source-journal">Semin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1055%2Fs-2000-9506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10895428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1-16&author=A.+Wasleyauthor=M.+J.+Alter&title=Epidemiology+of+hepatitis+C%3A+geographic+differences+and+temporal+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of hepatitis C: geographic differences and temporal trends</span></div><div class="casAuthors">Wasley A; Alter M J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in liver disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn">0272-8087</span>.
    </div><div class="casAbstract">Hepatitis C Virus (HCV) infection appears to be endemic in most parts of the world, with an estimated overall prevalence of 3%.  However, there is considerable geographic and temporal variation in the incidence and prevalence of HCV infection.  Using age-specific prevalence data, at least three distinct transmission patterns can be identified.  In countries with the first pattern (e.g., United States, Australia), most infections are found among persons 30-49 years old, indicating that the risk for HCV infection was greatest in the relatively recent past (10-30 years ago) and primarily affected young adults.  In countries with the second pattern (e.g., Japan, Italy), most infections are found among older persons, consistent with the risk for HCV infection having been greatest in the distant past.  In countries with the third pattern (e.g., Egypt), high rates of infection are observed in all age groups, indicating an ongoing high risk for acquiring HCV infection.  In countries with the first pattern, injection drug use has been the predominant risk factor for HCV infection, whereas in those with the second or third patterns, unsafe injections and contaminated equipment used in healthcare-related procedures appear to have played a predominant role in transmission.  Much of the variability between regions can be explained by the frequency and extent to which different risk factors have contributed to the transmission of HCV.  Because different strategies are required to interrupt different patterns of HCV transmission, determining the epidemiology of HCV infection in areas where that information has not yet been assessed is critical for developing appropriate prevention programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSp2wQyhQIHd7HHuJhbyicZfW6udTcc2ea_wDpd1zD3CLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D&md5=7c7736c5229d0104950eace9fa66a3fe</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-9506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-9506%26sid%3Dliteratum%253Aachs%26aulast%3DWasley%26aufirst%3DA.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DEpidemiology%2520of%2520hepatitis%2520C%253A%2520geographic%2520differences%2520and%2520temporal%2520trends%26jtitle%3DSemin.%2520Liver%2520Dis.%26date%3D2000%26volume%3D20%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brown, R. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaglio, P. J.</span><span> </span><span class="NLM_article-title">Scope of worldwide hepatitis C problem</span> <span class="citation_source-journal">Liver Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">S10</span><span class="NLM_x">–</span> <span class="NLM_lpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=S10-S13&author=R.+S.+Brownauthor=P.+J.+Gaglio&title=Scope+of+worldwide+hepatitis+C+problem"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26aulast%3DGaglio%26aufirst%3DP.%2BJ.%26atitle%3DScope%2520of%2520worldwide%2520hepatitis%2520C%2520problem%26jtitle%3DLiver%2520Transplant.%26date%3D2003%26volume%3D9%26spage%3DS10%26epage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Feld, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span> </span><span class="NLM_article-title">Mechanism of action of interferon and ribavirin in treatment of hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=967&author=J.+J.+Feldauthor=J.+H.+Hoofnagle&title=Mechanism+of+action+of+interferon+and+ribavirin+in+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeld%26aufirst%3DJ.%2BJ.%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26atitle%3DMechanism%2520of%2520action%2520of%2520interferon%2520and%2520ribavirin%2520in%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cuthbert, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C: Progress and Problems</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=7834603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1994&pages=505-532&author=J.+A.+Cuthbert&title=Hepatitis+C%3A+Progress+and+Problems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C: progress and problems</span></div><div class="casAuthors">Cuthbert J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-32</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV), a single-stranded RNA virus, is the major cause of posttransfusion hepatitis.  HCV isolates differ in nucleotide and amino acid sequences.  Nucleotide changes are concentrated in hypervariable regions and may be related to immune selection.  In most immunocompetent persons, HCV infection is diagnosed serologically, using antigens from conserved regions.  Amplification of RNA may be necessary to detect infection in immunosuppressed patients.  Transmission by known parenteral routes is frequent; other means of spread are less common and may represent inapparent, percutaneous dissemination.  Infection can lead to classical acute hepatitis, but most infected persons have no history of acute disease.  Once infected, most individuals apparently remain carriers of the virus, with varying degrees of hepatocyte damage and fibrosis ensuing.  Chronic hepatitis may lead to cirrhosis and hepatocellular carcinoma.  However, disease progression varies widely, from less than 2 years to cirrhosis in some patients to more than 30 years with only chronic hepatitis in others.  Determinants important in deciding outcome are unknown.  Alpha interferon, which results in sustained remission in selected patients, is the only available therapy.  Long-term benefits from such therapy have not been demonstrated.  Prevention of HCV infection by vaccination is likely to be challenging if ongoing viral mutation results in escape from neutralization and clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXDQuuyW-2sDEC-75aqa5AfW6udTcc2ebYCF474bEqirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D&md5=b4434f7061f607052197da39e1916b0a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuthbert%26aufirst%3DJ.%2BA.%26atitle%3DHepatitis%2520C%253A%2520Progress%2520and%2520Problems%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1994%26volume%3D7%26spage%3D505%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cohen, J.</span><span> </span><span class="NLM_article-title">The Scientific Challenge of Hepatitis C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=26-30&author=J.+Cohen&title=The+Scientific+Challenge+of+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DThe%2520Scientific%2520Challenge%2520of%2520Hepatitis%2520C%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Alter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszon-Moran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nainan, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, H. S.</span><span> </span><span class="NLM_article-title">The Prevalence of Hepatitis C Virus Infection in The United States, 1988 through 1994</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1056%2FNEJM199908193410802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10451460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=556-562&author=M.+J.+Alterauthor=D.+Kruszon-Moranauthor=O.+V.+Nainanauthor=G.+M.+McQuillanauthor=F.+Gaoauthor=L.+A.+Moyerauthor=R.+A.+Kaslowauthor=H.+S.+Margolis&title=The+Prevalence+of+Hepatitis+C+Virus+Infection+in+The+United+States%2C+1988+through+1994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</span></div><div class="casAuthors">Alter M J; Kruszon-Moran D; Nainan O V; McQuillan G M; Gao F; Moyer L A; Kaslow R A; Margolis H S</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">556-62</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population-based serologic studies are needed to estimate the prevalence of the infection and to develop and evaluate prevention efforts.  METHODS:  We performed tests for antibody to HCV (anti-HCV) on serum samples from 21,241 persons six years old or older who participated in the third National Health and Nutrition Examination Survey, conducted during 1988 through 1994.  We determined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of sequencing.  RESULTS:  The overall prevalence of anti-HCV was 1.8 percent, corresponding to an estimated 3.9 million persons nationwide (95 percent confidence interval, 3.1 million to 4.8 million) with HCV infection.  Sixty-five percent of the persons with HCV infection were 30 to 49 years old.  Seventy-four percent were positive for HCV RNA, indicating that an estimated 2.7 million persons in the United States (95 percent confidence interval, 2.4 million to 3.0 million) were chronically infected, of whom 73.7 percent were infected with genotype 1 (56.7 percent with genotype 1a, and 17.0 percent with genotype 1b).  Among subjects 17 to 59 years of age, the strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior.  Other factors independently associated with infection included poverty, having had 12 or fewer years of education, and having been divorced or separated.  Neither sex nor racial-ethnic group was independently associated with HCV infection.  CONCLUSIONS:  In the United States, about 2.7 million persons are chronically infected with HCV.  People who use illegal drugs or engage in high-risk sexual behavior account for most persons with HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTwajewlRkP_tos8R3JUhXfW6udTcc2ebYCF474bEqirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D&md5=d36f80ca56095fcd3cb19271f9e80dca</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1056%2FNEJM199908193410802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199908193410802%26sid%3Dliteratum%253Aachs%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26aulast%3DKruszon-Moran%26aufirst%3DD.%26aulast%3DNainan%26aufirst%3DO.%2BV.%26aulast%3DMcQuillan%26aufirst%3DG.%2BM.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DMoyer%26aufirst%3DL.%2BA.%26aulast%3DKaslow%26aufirst%3DR.%2BA.%26aulast%3DMargolis%26aufirst%3DH.%2BS.%26atitle%3DThe%2520Prevalence%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%2520in%2520The%2520United%2520States%252C%25201988%2520through%25201994%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D556%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Emerging therapies for Hepatitis C infection</span> <span class="citation_source-journal">Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1517%2F14728214.6.1.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=15989494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Srtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=13-42&author=B.+W.+Dymock&title=Emerging+therapies+for+Hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging therapies for hepatitis C virus infection</span></div><div class="casAuthors">Dymock, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Drugs</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-42</span>CODEN:
                <span class="NLM_cas:coden">EMDRFV</span>;
        ISSN:<span class="NLM_cas:issn">1361-9195</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 172 refs.  Hepatitis C virus (HCV) has infected millions of people worldwide and has emerged as a global health crisis.  The currently available therapy is interferon (IFN) either alone or in combination with ribavirin.  However, the disappointing efficacy of IFN has led to the considerable need for improved treatments and a no. of new therapies are under evaluation in clin. trials.  These include pegylated IFNs, which have altered physiochem. characteristics allowing once-weekly dosing.  Combination of pegylated IFN with ribavirin should further improve sustained response rates.  However, not all patients are successfully treated with IFNs, particularly those infected with genotype 1 of the virus, and it is likely that potent, specific drugs will be required.  The majority of new approaches currently trying to combat this viral disease are aimed at inhibition of viral targets.  Most effort has been directed towards inhibition of the NS3 serine protease, and potent inhibitors have now been described.  However, a clin. candidate is yet to emerge against this difficult target.  Considerable work by leading researchers has provided crystal structures of the key replicative enzymes, NS3 protease, NS3 helicase, NS5B polymerase and full-length NS3 protease-helicase, and there is much hope that such structural information will bear fruit.  More recently, inhibition of host targets, particularly inosine monophosphate dehydrogenase (IMPDH), has become of interest and there are on-going clin. trials with such inhibitors.  Research aimed at novel treatments for HCV disease is gathering pace and very recent developments in cell-based assay systems can only hasten the discovery of improved therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHjm4y0XuTNLVg90H21EOLACvtfcHk0lijYNCwEQM-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Srtbw%253D&md5=3f96a719833a9cf89bc565376fc7324e</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1517%2F14728214.6.1.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.6.1.13%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DEmerging%2520therapies%2520for%2520Hepatitis%2520C%2520infection%26jtitle%3DEmerging%2520Drugs%26date%3D2001%26volume%3D6%26spage%3D13%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"></span><span> </span><span class="NLM_article-title">Raffaele De Francesco and Giovanni Migliaccio</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=953-960&title=Raffaele+De+Francesco+and+Giovanni+Migliaccio"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DRaffaele%2520De%2520Francesco%2520and%2520Giovanni%2520Migliaccio%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Toniutto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirisi, M.</span><span> </span><span class="NLM_article-title">Antiviral treatment of hepatitis C</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2025</span><span class="NLM_x">–</span> <span class="NLM_lpage">2035</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1517%2F14656566.7.15.2025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=17020430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVarur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=2025-2035&author=P.+Toniuttoauthor=C.+Fabrisauthor=M.+Pirisi&title=Antiviral+treatment+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3fR"><div class="casContent"><span class="casTitleNuber">3f</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral treatment of hepatitis C</span></div><div class="casAuthors">Toniutto, Pierluigi; Fabris, Carlo; Pirisi, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2025-2035</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Therapy of hepatitis C virus (HCV) infection may prevent progression to cirrhosis, hepatocellular carcinoma and end-stage liver disease.  The cornerstone of treatment has long been std. IFN-α, the use of which was assocd. with a sustained biochem. and viral response in only a small proportion of patients.  More recently, the success of interferon-based regimens has substantially improved due to the combination with the guanosine analog ribavirin and to the advent of pegylated interferon formulations.  However, even the most up-to-date regimens fail to cure the infection in many cases and are limited by side effects and high costs.  A better understanding of the HCV genomic organization, the elucidation of the three-dimensional structures of virally encoded enzymes and the recent development of a HCV-replicon system in human hepatoma (Huh-7) cells have led to significant advances in the development of new antiviral compds., many of which are under evaluation in clin. trials.  The aim of this review is to trace a brief overview of the progress made by interferon-based treatments for hepatitis C since their introduction in the early 1990s, and to highlight the results of recent clin. studies concerning new and emerging drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_3dT3aXQ8bVg90H21EOLACvtfcHk0lhTkIsuD52rJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVarur7K&md5=a9946b7bf2018b1c72071f197920517b</span></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=10.1517%2F14656566.7.15.2025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.7.15.2025%26sid%3Dliteratum%253Aachs%26aulast%3DToniutto%26aufirst%3DP.%26aulast%3DFabris%26aufirst%3DC.%26aulast%3DPirisi%26aufirst%3DM.%26atitle%3DAntiviral%2520treatment%2520of%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2006%26volume%3D7%26spage%3D2025%26epage%3D2035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kolykhalov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1128%2FJVI.74.4.2046-2051.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10644379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2046-2051&author=A.+A.+Kolykhalovauthor=K.+Mihalikauthor=S.+M.+Feinstoneauthor=C.+M.+Rice&title=Hepatitis+C+virus-encoded+enzymatic+activities+and+conserved+RNA+elements+in+the+3%E2%80%B2+nontranslated+region+are+essential+for+virus+replication+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo</span></div><div class="casAuthors">Kolykhalov, Alexander A.; Mihalik, Kathy; Feinstone, Stephen M.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2046-2051</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a widespread major human health concern.  Significant obstacles in the study of this virus include the absence of a reliable tissue culture system and a small-animal model.  Recently, full-length HCV cDNA clones were constructed and HCV infection was successfully initiated in 2 chimpanzees by intrahepatic injection of in vitro-transcribed RNA.  In order to validate potential targets for development of anti-HCV therapeutics, 6 mutant derivs. of this prototype infectious clone were constructed.  Four clones contained point mutations ablating the activity of the NS2-3 protease, the NS3-4A serine protease, the NS3 NTPase/helicase, and the NS5B polymerase.  Two addnl. clones contained deletions encompassing all or part of the highly conserved 98-base sequence at the 3' terminus of the HCV genome RNA.  The RNA transcript from each of the 6 clones was injected intrahepatically into a chimpanzee.  No signs of HCV infection were detected in the 8 mo following the injection.  Inoculation of the same animal with nonmutant RNA transcripts resulted in productive HCV infection, as evidenced by viremia, elevated serum alanine aminotransferase, and HCV-specific seroconversion.  These data suggest that these 4 HCV-encoded enzymic activities and the conserved 3' terminal RNA element are essential for productive replication in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxsUWOuM9sLVg90H21EOLACvtfcHk0lhTkIsuD52rJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D&md5=69facc6778408ae96f31373f78c06600</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.4.2046-2051.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.4.2046-2051.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKolykhalov%26aufirst%3DA.%2BA.%26aulast%3DMihalik%26aufirst%3DK.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DHepatitis%2520C%2520virus-encoded%2520enzymatic%2520activities%2520and%2520conserved%2520RNA%2520elements%2520in%2520the%25203%25E2%2580%25B2%2520nontranslated%2520region%2520are%2520essential%2520for%2520virus%2520replication%2520in%2520vivo%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D2046%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, V.</span><span> </span><span class="NLM_article-title">Replication of hepatitis C virus</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1631</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1099%2F0022-1317-81-7-1631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10859368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks12iurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2000&pages=1631-48&author=R.+Bartenschlagerauthor=V.+Lohmann&title=Replication+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of hepatitis C virus</span></div><div class="casAuthors">Bartenschlager, Ralf; Lohmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1631-1648</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo14DohqSKFirVg90H21EOLACvtfcHk0lhTkIsuD52rJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks12iurg%253D&md5=a7f1e41501aa786af57605084b12df28</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1099%2F0022-1317-81-7-1631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F0022-1317-81-7-1631%26sid%3Dliteratum%253Aachs%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLohmann%26aufirst%3DV.%26atitle%3DReplication%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2000%26volume%3D81%26spage%3D1631%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinküler, C.</span><span> </span><span class="NLM_article-title">Recent developments in the discovery of hepatitis C virus serine protease inhibitors—towards a new class of antiviral agents</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=153-163&author=F.+Narjesauthor=U.+Kochauthor=C.+Steink%C3%BCler&title=Recent+developments+in+the+discovery+of+hepatitis+C+virus+serine+protease+inhibitors%E2%80%94towards+a+new+class+of+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DSteink%25C3%25BCler%26aufirst%3DC.%26atitle%3DRecent%2520developments%2520in%2520the%2520discovery%2520of%2520hepatitis%2520C%2520virus%2520serine%2520protease%2520inhibitors%25E2%2580%2594towards%2520a%2520new%2520class%2520of%2520antiviral%2520agents%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D153%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maitre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.-M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Maitreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rheaumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92Activity+Study+on+a+Novel+Series+of+Macrocyclic+Inhibitors+of+the+Hepatitis+C+Virus+NS3+Protease+Leading+to+the+Discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Maitre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592Activity%2520Study%2520on%2520a%2520Novel%2520Series%2520of%2520Macrocyclic%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Leading%2520to%2520the%2520Discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schairer, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drie, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span> </span><span class="NLM_article-title">Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1939</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1939-1942&author=R.+B.+Perniauthor=L.+J.+Farmerauthor=K.+M.+Cottrellauthor=J.+J.+Courtauthor=L.+F.+Courtneyauthor=D.+D.+Deiningerauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=J.+L.+Kimauthor=C.+Linauthor=K.+Linauthor=Y.-P.+Luongauthor=J.+P.+Maxwellauthor=M.+A.+Murckoauthor=J.+Pitlikauthor=B.+G.+Raoauthor=W.+C.+Schairerauthor=R.+D.+Tungauthor=J.+H.+Van+Drieauthor=K.+Wilsonauthor=J.+A.+Thomson&title=Inhibitors+of+hepatitis+C+virus+NS3%C2%B74A+protease.+Part+3%3A+P2+proline+variants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DFarmer%26aufirst%3DL.%2BJ.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DCourt%26aufirst%3DJ.%2BJ.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DMaxwell%26aufirst%3DJ.%2BP.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DPitlik%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DSchairer%26aufirst%3DW.%2BC.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DVan%2BDrie%26aufirst%3DJ.%2BH.%26aulast%3DWilson%26aufirst%3DK.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26atitle%3DInhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%25C2%25B74A%2520protease.%2520Part%25203%253A%2520P2%2520proline%2520variants%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1939%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">Novel P4 truncated tripeptidyl α-ketoamides as HCV protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=263-266&author=J.+Lamarauthor=F.+Victorauthor=N.+Snyderauthor=R.+B.+Johnsonauthor=Q.+M.+Wangauthor=J.+I.+Glassauthor=S.-H.+Chen&title=Novel+P4+truncated+tripeptidyl+%CE%B1-ketoamides+as+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DNovel%2520P4%2520truncated%2520tripeptidyl%2520%25CE%25B1-ketoamides%2520as%2520HCV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D263%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malancona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2151</span><span class="NLM_x">–</span> <span class="NLM_lpage">2154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2151-2154&author=E.+Niziauthor=U.+Kochauthor=J.+M.+Ontoriaauthor=A.+Marchettiauthor=F.+Narjesauthor=S.+Malanconaauthor=V.+G.+Matassaauthor=C.+Gardelli&title=Capped+dipeptide+phenethylamide+inhibitors+of+the+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DCapped%2520dipeptide%2520phenethylamide%2520inhibitors%2520of%2520the%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2151%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Priestley, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavimi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span> </span><span class="NLM_article-title">P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3199</span><span class="NLM_x">–</span> <span class="NLM_lpage">3202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3199-3202&author=E.+S.+Priestleyauthor=I.+De+Luccaauthor=B.+Ghavimiauthor=S.+Erickson-Viitanenauthor=C.+P.+Decicco&title=P1+Phenethyl+peptide+boronic+acid+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26aulast%3DDe%2BLucca%26aufirst%3DI.%26aulast%3DGhavimi%26aufirst%3DB.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26atitle%3DP1%2520Phenethyl%2520peptide%2520boronic%2520acid%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3199%26epage%3D3202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as Hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5751</span><span class="NLM_x">–</span> <span class="NLM_lpage">5755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5751-5755&author=A.+Arasappanauthor=F.+G.+Njorogeauthor=T.+N.+Parekhauthor=X.+Yangauthor=J.+Pichardoauthor=N.+Butkiewiczauthor=A.+Prongayauthor=N.+Yaoauthor=V.+Girijavallabhan&title=Novel+2-oxoimidazolidine-4-carboxylic+acid+derivatives+as+Hepatitis+C+virus+NS3-4A+serine+protease+inhibitors%3A+synthesis%2C+activity%2C+and+X-ray+crystal+structure+of+an+enzyme+inhibitor+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DParekh%26aufirst%3DT.%2BN.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DNovel%25202-oxoimidazolidine-4-carboxylic%2520acid%2520derivatives%2520as%2520Hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%2520inhibitors%253A%2520synthesis%252C%2520activity%252C%2520and%2520X-ray%2520crystal%2520structure%2520of%2520an%2520enzyme%2520inhibitor%2520complex%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5751%26epage%3D5755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><div class="note"><p class="first last">For BILN-2061, see:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+BILN-2061%2C+see%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=T.+S.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0liLfNQSuY_gDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DGeorge%26aufirst%3DT.%2BS.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1355-1360&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Gordreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+Inhibitors+of+the+NS3+Protease+as+Potential+Therapeutic+Agents+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGordreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520the%2520NS3%2520Protease%2520as%2520Potential%2520Therapeutic%2520Agents%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1355%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DurKin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1005-1008&author=R.+Zhangauthor=J.+P.+DurKinauthor=W.+T.+Windsor&title=Azapeptides+as+inhibitors+of+the+hepatitis+C+virus+NS3+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDurKin%26aufirst%3DJ.%2BP.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DAzapeptides%2520as%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1005%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2-P1 cyclopropyl alanine combination for improved potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4515-4519&author=S.+L.+Bogenauthor=A.+K.+Saksenaauthor=A.+Arasappanauthor=H.+Guauthor=F.+G.+Njorogeauthor=V.+Girijavallabhanauthor=J.+Pichardoauthor=N.+Butkiewiczauthor=A.+Prongayauthor=V.+Madison&title=Hepatitis+C+virus+NS3-4A+serine+protease+inhibitors%3A+use+of+a+P2-P1+cyclopropyl+alanine+combination+for+improved+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DHepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%2520inhibitors%253A%2520use%2520of%2520a%2520P2-P1%2520cyclopropyl%2520alanine%2520combination%2520for%2520improved%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4515%26epage%3D4519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span> </span><span class="NLM_article-title">α-Ketoamides, α-ketoesters and α-diketones as HCV NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=711-713&author=W.+Hanauthor=Z.+Huauthor=X.+Jiangauthor=C.+P.+Decicco&title=%CE%B1-Ketoamides%2C+%CE%B1-ketoesters+and+%CE%B1-diketones+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26atitle%3D%25CE%25B1-Ketoamides%252C%2520%25CE%25B1-ketoesters%2520and%2520%25CE%25B1-diketones%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D711%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumibe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=257-261&author=F.+Victorauthor=J.+Lamarauthor=N.+Snyderauthor=Y.+Yipauthor=D.+Guoauthor=N.+Yumibeauthor=R.+B.+Johnsonauthor=Q.+M.+Wangauthor=J.+I.+Glassauthor=S.-H.+Chen&title=P1+and+P3+optimization+of+novel+bicycloproline+P2+bearing+tetrapeptidyl+%CE%B1-ketoamide+based+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DN.%26aulast%3DYip%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYumibe%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DP1%2520and%2520P3%2520optimization%2520of%2520novel%2520bicycloproline%2520P2%2520bearing%2520tetrapeptidyl%2520%25CE%25B1-ketoamide%2520based%2520HCV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D257%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><div class="note"><p class="first last">For SCH 503034, see:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+SCH+503034%2C+see%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J. J.</span><span> </span><span class="NLM_article-title">Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=50-59&author=F.+G.+Njorogeauthor=K.+X.+Chenauthor=N.-Y.+Shihauthor=J.+J.+Piwinski&title=Challenges+in+Modern+Drug+Discovery%3A+A+Case+Study+of+Boceprevir%2C+an+HCV+Protease+Inhibitor+for+the+Treatment+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Far700109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700109k%26sid%3Dliteratum%253Aachs%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26atitle%3DChallenges%2520in%2520Modern%2520Drug%2520Discovery%253A%2520A%2520Case%2520Study%2520of%2520Boceprevir%252C%2520an%2520HCV%2520Protease%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D50%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)-amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable, hepatitis C virus NS3 protease inhibitor: A potential therapeutic agent for the treatment of hepatitis C infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=T.+Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2-3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29-amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexane-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable%2C+hepatitis+C+virus+NS3+protease+inhibitor%3A+A+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2-3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529-amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexane-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%252C%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520A%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.+P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.%2BP.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khunvichai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span> </span><span class="NLM_article-title">Antiviral effects and safety of telaprevir peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1016%2Fj.jhep.2008.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=18486984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlWqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=163-169&author=E.+Lawitzauthor=M.+Rodriguez-Torresauthor=A.+J.+Muirauthor=T.+L.+Kiefferauthor=L.+McNairauthor=A.+Khunvichaiauthor=J.+G.+McHutchison&title=Antiviral+effects+and+safety+of+telaprevir+peginterferon+alfa-2a%2C+and+ribavirin+for+28+days+in+hepatitis+C+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients</span></div><div class="casAuthors">Lawitz, Eric; Rodriguez-Torres, Maribel; Muir, Andrew J.; Kieffer, Tara L.; McNair, Lindsay; Khunvichai, Ariya; McHutchison, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-169</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study assessed the safety and antiviral effects of telaprevir (VX-950) in combination with peginterferon alfa-2a and ribavirin.  Twelve treatment-naive patients with chronic genotype 1 hepatitis C virus infection received telaprevir (750 mg q8h), peginterferon alfa-2a (180 μg/wk), and ribavirin (1000 or 1200 mg/day) for 28 days.  Patients could then start off-study treatment with peginterferon alfa-2a and ribavirin for up to 44 wk, at the discretion of the investigator and patient.  The combination of telaprevir, peginterferon alfa-2a, and ribavirin was well tolerated, with no serious adverse events or treatment discontinuations.  Rash or pruritus occurred in 5 of the 12 patients; all cases resolved either during or after the end of telaprevir treatment.  All 12 patients had undetectable HCV RNA levels by day 28 (rapid viral response, RVR).  Eight patients completed 44 wk of off-study peginterferon alfa-2a and ribavirin treatment.  Eight patients achieved a sustained viral response (SVR), including one patient who received only 22 wk of treatment.  The combination of telaprevir, peginterferon alfa-2a, and ribavirin was generally well tolerated.  Events of pruritus and rash resolved during or after end of telaprevir dosing.  All 12 patients achieved an RVR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaZPUDf_0tJLVg90H21EOLACvtfcHk0ljMX_rR6jw1Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlWqsbo%253D&md5=2a5f653f8cfe56c4501907397886aad6</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2008.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2008.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DMuir%26aufirst%3DA.%2BJ.%26aulast%3DKieffer%26aufirst%3DT.%2BL.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DKhunvichai%26aufirst%3DA.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26atitle%3DAntiviral%2520effects%2520and%2520safety%2520of%2520telaprevir%2520peginterferon%2520alfa-2a%252C%2520and%2520ribavirin%2520for%252028%2520days%2520in%2520hepatitis%2520C%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2008%26volume%3D49%26spage%3D163%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mederacke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M.</span><span> </span><span class="NLM_article-title">P Boceprevir an NS3 serine protease inhibitor of hepatitis C virus for the treatment of HCV infection</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=19197796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1Kitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=181-9&author=I.+Mederackeauthor=H.+Wedemeyerauthor=M.+Manns&title=P+Boceprevir+an+NS3+serine+protease+inhibitor+of+hepatitis+C+virus+for+the+treatment+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection</span></div><div class="casAuthors">Mederacke, Ingmar; Wedemeyer, Heiner; Manns, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (BioMed Central)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-189</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">2040-3429</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Boceprevir is an HCV NS3 (non-structural protein 3) serine protease inhibitor being developed by Schering-Plough Corp as a capsule formulation.  In pharmacokinetic studies, boceprevir was adequately absorbed, with the most effective mode of administration appearing to be a three-times-daily regimen.  In phase I clin. trials, monotherapy with baceprevir led to a distinct viral load redn.  In phase 1b combination trials of baceprevir with PEGylated IFNα2b and ribavirin, the redn. in viral replication was further increased.  Early data reported from phase II clin. trials have been promising, suggesting a rapid early HCV-RNA redn.  Phase III trials for the drug began in 2008.  Results available to date have demonstrated the compd. to be well tolerated, with adverse events that were within the range of current std.-of-care therapy.  Thus, boceprevir may have the potential to increase sustained virol. response rates and possibly also to shorten duration of therapy; data from ongoing clin. trials are awaited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLYKUOStRMTbVg90H21EOLACvtfcHk0ljMX_rR6jw1Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1Kitb8%253D&md5=bbe724393fa436b8740b5d8fde25b1c9</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMederacke%26aufirst%3DI.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DManns%26aufirst%3DM.%26atitle%3DP%2520Boceprevir%2520an%2520NS3%2520serine%2520protease%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520for%2520the%2520treatment%2520of%2520HCV%2520infection%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D181%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, Michael, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Bang-Lin; Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=T.+B.+Rudd%2C+Michaelauthor=W.+Johnauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=D.+B.+Wan%2C+Bang-Lin%3B+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%252C%2BMichael%26aufirst%3DT.%2BB.%26aulast%3DJohn%26aufirst%3DW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%252C%2BBang-Lin%253B%2BOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zeuzem, S.; Sarrazin, C.; Rouzier, R.; Tarral, A.; Brion, N.; Forestier, N.; Gupta, S.; Deckman, D.; Fellows, K.; Hussain, M.; Cutler, D.; Zhang, J.</span> In <span class="NLM_conf-name">56th Annual Meeting of AASLD</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zeuzem%2C+S.%3B+Sarrazin%2C+C.%3B+Rouzier%2C+R.%3B+Tarral%2C+A.%3B+Brion%2C+N.%3B+Forestier%2C+N.%3B+Gupta%2C+S.%3B+Deckman%2C+D.%3B+Fellows%2C+K.%3B+Hussain%2C+M.%3B+Cutler%2C+D.%3B+Zhang%2C+J.+In+56th+Annual+Meeting+of+AASLD%2C+San+Francisco%2C+CA%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZeuzem%26aufirst%3DS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For combination therapy with pegylated interferon α-2b see</p></div> : <span class="NLM_contrib-group">Sarrazin, C.; Rouzier, R.; Wagner, F.; Forestier, N.; Larrey, D.; Gupta, S. K.; Hussain, M.; Shah, A.; Cutler, D.; Zhang, J.; Zeuzem, S.</span><span> </span><span class="NLM_article-title">SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders</span>.  <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span>− <span class="NLM_lpage">1278</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=1270-1278&author=C.+Sarrazin&author=R.+Rouzier&author=F.+Wagner&author=N.+Forestier&author=D.+Larrey&author=S.+K.+Gupta&author=M.+Hussain&author=A.+Shah&author=D.+Cutler&author=J.+Zhang&author=S.+Zeuzem&title=SCH+503034%2C+a+Novel+Hepatitis+C+Virus+Protease+Inhibitor%2C+Plus+Pegylated+Interferon+%CE%B1-2b+for+Genotype+1+Nonresponders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarrazin%26aufirst%3DC.%26atitle%3DSCH%2520503034%252C%2520a%2520Novel%2520Hepatitis%2520C%2520Virus%2520Protease%2520Inhibitor%252C%2520Plus%2520Pegylated%2520Interferon%2520%25CE%25B1-2b%2520for%2520Genotype%25201%2520Nonresponders%26jtitle%3DGastroenterology%26date%3D2007%26volume%3D132%26spage%3D1270%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pfitzner, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffatt, J. G.</span><span> </span><span class="NLM_article-title">A new and selective oxidation of alcohols</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3027</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00902a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADyaF3sXkvVantbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1963&pages=3027&author=K.+E.+Pfitznerauthor=J.+G.+Moffatt&title=A+new+and+selective+oxidation+of+alcohols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of nucleoside 5'-carboxaldehydes</span></div><div class="casAuthors">Pfitzner, K. E.; Moffatt, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3027</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Addn. of dicyclohexylcarbodiimide (I) to an anhyd. soln. of pyridinium thymidine 5'-phosphate in Me2SO after 1 hr. at room temp. gave thymine (II) and inorg. phosphates.  A similar release of II resulted from P1,P2-dithymidine pyrophosphate, thymidine, and 5'-O-acetylthymidine, but not from 3'-O-acetylthymidine 5'phosphate, 3'-deoxythymidine 5'-phosphate, or the corresponding nucleosides in the presence of phosphate.  Treatment of 1 millimole 3'-O-acetylthymidine in 3 ml. anhyd. Me2SO contg. 0.5 millimole phosphoric acid with 3-5 millimoles I for several hrs. at room temp. gave no release of II, but rather 3'-O-acetyl thymidine 5'-carboxaldehyde (III), λ 267 mμ in H2O [2,4-di-nitrophenylhydrazone m. 233-34°,  (MeOH) 261 and 350 mμ (ε 19,300 and 21,650)], completely free of acidic nucleoside derivs. Redn. of III with NaBH4 gave II, while oxidn. of III with NaOI gave 3'-O-acetylthymidine 5'-carboxylic acid, which on alk. hydrolysis gave thymidine 5'-carboxylic acid. Similarly, the reaction of 2',3'-O-isopropylideneuridine and 2',3'-O-iso-propylideneadenosine with I and 0.5 mole-equiv. pyridinium trifluoroacetate or pyridinium phosphate in anhyd.  Me2SO, followed by treatment with 10% HOAc at 100° for 1 hr., gave uridine 5'carboxaldehyde and adenosine 5'-carboxaldehyde.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-8EJfx87wgbVg90H21EOLACvtfcHk0liWMPbi2cBkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXkvVantbY%253D&md5=3f46daf90e60de38496a7379b113674e</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fja00902a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00902a036%26sid%3Dliteratum%253Aachs%26aulast%3DPfitzner%26aufirst%3DK.%2BE.%26aulast%3DMoffatt%26aufirst%3DJ.%2BG.%26atitle%3DA%2520new%2520and%2520selective%2520oxidation%2520of%2520alcohols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1963%26volume%3D85%26spage%3D3027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dess, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">A Useful 12-I-5 Triacetoxyperiodinane (the Dess−Martin Periodinane) for the Selective Oxidation of Primary or Secondary Alcohols and a Variety of Related 12-I-5 Species</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">7277</span><span class="NLM_x">–</span> <span class="NLM_lpage">7287</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00019a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=7277-7287&author=D.+B.+Dessauthor=J.+C.+Martin&title=A+Useful+12-I-5+Triacetoxyperiodinane+%28the+Dess%E2%88%92Martin+Periodinane%29+for+the+Selective+Oxidation+of+Primary+or+Secondary+Alcohols+and+a+Variety+of+Related+12-I-5+Species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fja00019a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00019a027%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DA%2520Useful%252012-I-5%2520Triacetoxyperiodinane%2520%2528the%2520Dess%25E2%2588%2592Martin%2520Periodinane%2529%2520for%2520the%2520Selective%2520Oxidation%2520of%2520Primary%2520or%2520Secondary%2520Alcohols%2520and%2520a%2520Variety%2520of%2520Related%252012-I-5%2520Species%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D7277%26epage%3D7287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Peterson, D. J.</span><span> </span><span class="NLM_article-title">Carbonyl olefination reaction using silyl-substituted organometallic compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1968&pages=780-784&author=D.+J.+Peterson&title=Carbonyl+olefination+reaction+using+silyl-substituted+organometallic+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DD.%2BJ.%26atitle%3DCarbonyl%2520olefination%2520reaction%2520using%2520silyl-substituted%2520organometallic%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1968%26volume%3D34%26spage%3D780%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B. A.</span><span> </span><span class="NLM_article-title">A Continuous Spectrophotometric Assay for the Hepatitis C Virus Serine Protease</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><div class="note"><p class="first last">The substrate Ac-DTEDVVP(Nva)-O-PAP was used in the present study</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1999&pages=268-275&author=R.+Zhangauthor=B.+M.+Beyerauthor=J.+Durkinauthor=R.+Ingramauthor=F.+G.+Njorogeauthor=W.+T.+Windsorauthor=B.+A.+Malcolm&title=A+Continuous+Spectrophotometric+Assay+for+the+Hepatitis+C+Virus+Serine+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26atitle%3DA%2520Continuous%2520Spectrophotometric%2520Assay%2520for%2520the%2520Hepatitis%2520C%2520Virus%2520Serine%2520Protease%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D270%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm801632a&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm801632a&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm801632a&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+Kornerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0lg8336UUUm_kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uss, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span> </span><span class="NLM_article-title">Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1186</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=1186-1197&author=C.+Liauthor=L.+Nairauthor=T.+Liuauthor=F.+Liauthor=J.+Pichardoauthor=S.+Agrawalauthor=R.+Chaseauthor=X.+Tongauthor=A.+S.+Ussauthor=S.+Bogenauthor=F.+G.+Njorogeauthor=R.+A.+Morissonauthor=K.-C.+Cheng&title=Correlation+between+PAMPA+permeability+and+cellular+activities+of+hepatitis+C+virus+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DNair%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DUss%26aufirst%3DA.%2BS.%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMorisson%26aufirst%3DR.%2BA.%26aulast%3DCheng%26aufirst%3DK.-C.%26atitle%3DCorrelation%2520between%2520PAMPA%2520permeability%2520and%2520cellular%2520activities%2520of%2520hepatitis%2520C%2520virus%2520protease%2520inhibitors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D1186%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OBO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OBO','PDB','2OBO'); return false;">PDB: 2OBO</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm801632a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-12%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm801632a%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm801632a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                336KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a2e8289c43d30","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
